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SUMMARY
Meningococcal disease remains a major public health concern, especially in the
African Meningitis Belt where large meningitis epidemics with attack rates of up to
500/100,000 recur every 8-12 years. The factors precipitating epidemics are largely
unknown. Epidemics are therefore unpredictable which often leads to control
measures being initiated too late to be effective. Following a major meningitis
epidemic that occurred in northern Ghana in 1997, a collaborative research project
was developed between the Swiss Tropical Institute and the Navrongo Health
Research Center, in order to address several research questions relevant to the
epidemiology of meningococcal disease in Ghana. This research partnership built the
framework of the present thesis, which concentrated on the molecular epidemiological
aspects of the project.
During the dry season of 1998, there was a second meningitis outbreak in the
Kassena-Nankana district (KND) of northern Ghana. All suspected meningitis
patients were recruited at the local health facilities, lumbar punctures carried out
before treatment and the cerebrospinal fluid (CSF) specimen sent to the field
laboratory for analysis. In 50 of 92 CSF samples analyzed, serogroup A Neisseria
meningitidis were detected. All serogroup A N. meningitidis olates recovered were
of the A:4:P1.9,20 phenotype. Analysis of representative isolates by multilocus
sequence typing (MLST) and by restriction fragment length polymorphism (RFLP) of
opa, iga and ingA genes showed that they belonged to subgroup III (sequence type 5)
of N. meningitidis and had RFLP patterns characteristic of serogroup A subgroup III
bacteria isolated in Africa after the 1987 Mecca epidemic.  RFLP analysis of six
polymorphic loci in a global collection of 502 isolates of subgroup III, serogroup A N.
meningitidis dentified nine ‘genoclouds’, consisting of genotypes that were isolated
repeatedly, plus 48 less frequent descendent genotypes.
Starting during the second outbreak, a series of five 6-monthly carriage surveys
of 37 randomly selected households were carried out in KND. As serogroup A N.
meningitidis carriage decreased, that of X meningococci increased dramatically to
reach 18% (53/298) of the people sampled during the dry season of 2000.  This
coincided with a further outbreak of disease, this time caused by serogroup X.  The
Ghanaian serogroup X strains were analyzed by MLST and pulsed-field gel
electrophoresis (PFGE) along with other serogroup X isolates from different countries
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of Africa, Europe and North America. The European and American isolates were
highly diverse. However, one clonal grouping was identified among sporadic disease
and carrier strains isolated over the last two decades in the UK, The Netherlands,
Germany and the USA. In contrast to the diversity among the European and American
isolates, most carrier and disease isolates recovered in Ghana and other countries of
the African Meningitis Belt over the last thirty years belong to a second cl n l
grouping. Based on the PFGE results, two genoclouds were identified within the
second clonal grouping, one of which caused an outbreak in Niger in 1997 and the
other of which caused the outbreak in KND in 2000.
Patterns of carriage of N. lactamica in KND were unrelated to those of N.
meningitidis.  Non-serogroupable (NG) strains of N. meningitidis were infrequent.
This contrasts with industrialized countries where asymptomatic nasopharyngeal
carriage of N. meningitidis  common and up to 50% of the strains carried are NG.
The nine genoclouds of subgroup III meningococci have caused three pandemic
waves of disease since the mid-1960’s, with the 1997-8 outbreaks in KND forming
part of the second wave. The third wave was imported from East Asia to Europe and
Africa in the mid-1990s, and may well lead to renewed epidemic serogroup A disease
in Europe and the Americas. The finding that a serogroup X meningococcal clonal
grouping has caused outbreaks in Africa, supports concerns that polysaccharide
vaccines, which have been in use for more than a decade might be selecting for non-
vaccine serogroups and argues for the development of a comprehensive conjugate
vaccine including serogroup X polysaccharide. The dynamics of eningococcal
carriage that were observed in KND suggest that in the African meningitis belt, the
populations become colonized in waves of different meningococcal strains, and the
occurrence of epidemics of disease depends on the virulence of these strains. Carriage
of NG meningococci may protect against me ingococcal disease by eliciting cross-
reactive immunity against pathogenic strains and the low levels of carriage of such
organisms in the African meningitis belt may thus increase susceptibility to
epidemics.
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Meningokokken-Meningitis ist ein Gesundheitsproblem von weltweiter
Bedeutung. Grosse Epidemien mit Inzidenzen von über 500/100‘000 treten
regelmässig alle 8-12 Jahre im Afrikanischen Meningitisgürtel auf. Die Faktoren, die
zu diesen Epidemien führen sind grösstenteils unbekannt und Kontrollmassnahmen
werden dadurch oft zu spät eingeleitet. Im  Jahre 1997 wurde der Norden Ghanas von
einer schweren Epidemie heimgesucht. Eine wissenschaftliche Zusammenarbeit
zwischen dem Schweizerischen Tropeninstitut und dem Navrongo Health Resarch
Center wurde daraufhin ins Leben gerufen, mit dem Ziel, verschiedene
Fragestellungen zur Epidemiologie der Meningokokken-Meningitis in Ghana
anzugehen. Diese wissenschaftliche Zusammenarbeit bildete den Rahmen für diese
Dissertation, die sich mit den molekular-epidemiologischen Aspekten befasst hat.
Während der Trockenzeit des Jahres 1998, traf eine zweite Meningitis Epidemie
den Kassena-Nankana Distrikt (KND) im Norden Ghanas. Meningitis Patienten
wurden im Distriktspital and an den Gesundheitszentren rekrutiert. Eine
Lumbarpunktion wurde vor der Behandlung durchgeführt und die Liquorproben zum
Feldlabor transportiert. Serogruppe A Neisseria meningitidis konnte in 50 von 92
analysierten Liquorproben  identifiziert werden. Alle kultivierten Serogruppe A N.
meningitidis Stämme hatten den Phänotyp A:4:P1.9,29. Eine Anzahl repräsentativer
Stämme wurde mit „Mulilocus Sequence Typing“ (MLST) und „Restriction Fragment
Length Polymorphism“ (RFLP) von opa, iga und ingA Genen analysiert. Diese
Analysen zeigten, dass diese Bakterien zur Subgruppe III (Sequenztyp 5) von N.
meningitidis gehören. Ihre RFLP Muster waren charakteristisch für Serogruppe A,
Subgruppe III Meningokokken, die nach der 1987er Epidemie in Mekka in Afrika
isoliert wurden. Die genetische Variabilität einer globalen Sammlung von 502
Subgruppe III Isolate wurde mit RFLP von 6 polymorphen Loci analysiert. Neun
„Genoclouds“ wurden dabei identifiziert, die aus Genotypen bestehen, die öfters
isoliert wurden. Daneben wurden weitere 48 verwandte, aber seltene Genotypen
gefunden.
Während der zweiten Meningitis-Epidemie im KND, wurde eine Serie von fünf
Trägerstudien gestartet, in der 37 zufällig ausgewählte Haushalte halbjährlich besucht
wurden. Während die Serogruppe A N. meningitidis Trägerrate abnahm, stieg
diejenige von Serogruppe X Meningokokken dramatisch an und erreichte 18% (53
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von 298 getesteten Personen) in der Trockenzeit des Jahres 2000. Eine weitere
Meningitis-Epidemie, diesmal  durch Serogruppe X verursacht, begleitete diesen
Anstieg der Trägerrate.
Die Ghanaischen Serogruppe X Stämme wurden zusammen mit einer
Sammlung von anderen Serogruppe X Isolaten aus verschiedenen europäischen,
amerikanischen und afrikanischen Ländern mit MLST und Pulsfeld Gel
Elektrophorese (PFGE) analysiert. Die europäischen und amerikanischen Stämme
waren sehr unterschiedlich. Eine klonale Gruppe wurde aber identifiziert, bestehend
aus Isolaten von gesunden Trägern und von sporadischen Krankheitsfällen, die
während den letzten beiden Jahrzehnten in Grossbritanien, Holland, Deuschland und
USA isoliert worden waren. Im Gegensatz zu der Heterogenität der europäischen und
amerikanischen Isolate gehört die Mehrheit der Stämme, die in den letzen 30 Jahren
in Ghana und in anderen Ländern des Afrikanischen Meningitisgürtels isoliert
wurden, zu einer klonalen Gruppe. PFGE Resultate zeigten, dass diese klonale
Gruppe sich in zwei „Genoclouds“ aufteilen lässt. Bakterien der einen „Genocloud“
haben eine Epidemie in 1997 in Niger verursacht und Bakterien der anderen die
2000er Epidemie im KND.
Die Kolonisation des Nasopharynx mit N. lactamica hatte keinen Einfluss auf
diejenige mit N. meningitidis. Nicht-serogruppierbare (NG) Stämme waren selten,
was im Gegensatz zu den Industriestaaten steht, wo Trägertum häufig ist und bis zu
50% der Trägerisolate NG sind.
Die 9 „Genoclouds“ der Subgruppe III Meningokokken haben seit den 1960er
Jahren drei pandemische Krankheitswellen verursacht. Die 1997-8er Epidemie im
KND war Teil der zweiten dieser Wellen. Die dritte Welle wurde in den 1990er
Jahren aus Ostasien nach Europa und Afrika importiert und könnte zu einem neuen
Aufkommen von epidemischer Serogruppe A Krankheit in Europe führen. Die
Tatsache, dass eine Serogruppe X klonale Gruppe mehrere Epidemien in Afrika
verursacht hat, unterstützt den Gedanken, dass die Polysaccharid Impfstoffe, die in
Afrika seit mehr als 10 Jahren intensiv verwendet werden, Serogruppen
selektionieren, die nicht im Impfstoff enthalten sind. Diese Resultate sprechen dafür,
einen umfassenden Konjugatimpfstoff zu entwickeln, der auch Serogruppe X
Polysaccharid enthält.
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Die Dynamik des Meningokokken Trägertums im KND deutet darauf hin, dass
die Populationen im Afrikanischen Meningitisgürtel durch verschiedene
Meningokokkenstämme wellenartig kolonisiert werden, und dass das Aufkommen
von Epidemien von der Virulenz dieser Stämme abhängt. Im Hinblick darauf, dass
das Trägertum von NG Stämmen vor Meningokokken Erkrankung schützen könnte,
indem es kreuz-reagierende Immunität fördert, könnte eine geringe Trägerrate solcher
Organismen im Afrikanischen Meningitisgürtel zu einer erhöhten Empfindlichkeit für
Epidemien führen.
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CHAPTER 1. Introduction2
1.1 The history of meningococcal meningitis in Africa1
The first clear account of an outbreak of meningococcal meningitis, sometimes
called cerebrospinal meningitis (CSM), is given by V eusseux (1806), who described a
typical epidemic that occurred in 1805 in Geneva, Switzerland. Cases may have
occurred previously, lost among reports of ‘spotted fevers’, but large epidemics of
CSM are so dramatic that it seems unlikely that these would have passed unreported
by the observant physicians who practiced in Europe in the 17th and 18th centuries
(Greenwood 1999). In 1806, another typical outbreak was described in Medfield,
Massachusetts, USA, the first report of the disease in the New World (Danielson&
Mann 1806). Throughout the 19th and early part of the 20th centuries, outbreaks of
CSM occurred on many occasions across the USA and throughout Europe.
The causative agent of CSM, a Gram-negative diplocococcus initially called
Diplococcus intracellularis but now known as Neisseria meningitidis (the
meningococcus), was described for the first time in 1984 (Marchiafava 1884), and was
first cultured from patients with CSM by Weichselbaum in Vienna (1887).
When epidemic CSM first reached West Africa and how it got there will
probably never be known definitely but it is likely that the first major epidemics
occurred around 100 years ago. Evidence that epidemic CSM was not prevalent before
that time comes from 3 main sources – early African literature, reports from the first
European explorers to West Africa and accounts obtained from the local population at
the time that the first major epidemics were reported (G enwood 1999). The first
proven outbreak of CSM in West Africa, established by the detection of diplococci in
cerebrospinal fluid, occurred in Northern Nigeria in 1905 (McGahey 1905). Several
recent epidemics of CSM in Africa have been caused by meningococci introduced into
West Africa by pilgrims on their return from the Hajj (Morelli et al. 1997) and it has
been hypothesized that the meningococcus responsible for the 1905 epidemic in
Nigeria was brought in by the same process (G eenwood 1999).
In the Gold Coast (Ghana), an epidemic of CSM was reported for the first time
in 1906; it seems probable that this was caused by the same epidemic strain that
caused the Nigerian outbreak. The epidemic started in the north-west of the Gold
Coast, spread widely throughout the area during the following dry season (Horn 1908).
                                                
1 This section is mainly taken from the Manson Lecture by Greenwood (1999).
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It spread rapidly westwards into the territories under French colonial rule and
outbreaks of CSM have occurred across West Africa every few years ever since. In
Ghana, epidemics were subsequently reported in 1919/20, in 1939/40, in 1945, in
1949/50 (Waddy 1957), in 1961, in 1972/73 (Belcher et al. 1977), in 1984 (A.
Amankwa, personal communication) and in 1997/98 (Tikhomirov et al. 1997).
 Figure 1.1. The African Meningitis Belt (Source: Moore 1992).
An extensive survey of published and unpublished records, many obtained by
personal visits to hospitals and ministries of health across West Africa, enabled
Lapeyssonnie (1963) to produce the definitive report on CSM in West Africa during
the first half of the 20th century: La méningite cérébrospinale en Afrique
(Lapeyssonnie 1963). He documented in detail the epidemiological features of CSM in
Africa and drew attention to the fact that it is only in a restricted area of Africa that the
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infection behaves in such a characteristic and peculiar way. This led him to define the
‘African meningitis belt’, bounded to the north by the Sahara and to the south by areas
of tropical rain forest. In the 36 years since it was first published the concept of the
African meningitis belt has held up well. However, it is now known that the belt
extends further west than originally envisaged, reaching as far as Senegal, Guinea and
the eastern half of The Gambia (Moore 1992) (Figure 1.1).
1.2 The epidemiology of meningococcal meningitis in Africa today
The current epidemiology of meningoccocal meningitis in Africa differs little
from that described by Lapeyssonnie in 1963. It has been suggested that epidemics
have become more frequent and that they have lost some of their periodicity but this is
difficult to document as epidemics have always occurred in an unpredictable way
(Greenwood 1999). The characteristic epidemiological features of epidemic
meningococcal meningitis in Africa are summarized below.
Periodicity
Within individual countries of the meningitis belt, major epidemics of
meningococcal meningitis occur with a periodicity of 8-12 years (Moore 1992); the
pattern of epidemics in Burkina Faso shown in Figure 1.2 is characteristic. Although
the incidence of meningococcal infection falls markedly between epidemics, it
nevertheless remains several times higher than that found in industrialized countries
(Tikhomirov et al. 1997). In the African meningitis belt, major epidemics usually last
for 2 or 3 dry seasons, dying out during the intervening rainy season (Moore 1992).
Size
African epidemics of meningococcal meningitis are often enormous with attack
rates that may exceed 500 per 100,000 population. In 1921, an epidemic in Nigeria
caused 45,000 deaths in Sokoto Province (population 1.36 million) alone (Blaire
1921). In 1996, 80,000 cases were reported in Nigeria and 40,000 in Burkina Faso
(Tikhomirov et al. 1997). One year later, 20,000 cases occurred again in Burkina Faso,
20,000 in Ghana, and 10,000 in Mali. In 1999, more than 30,000 cases occurred in
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Sudan (WHO 1999), and more than 10,000 occurred in Niger in 2000 (WHO 2000a).
Figures such as these, massive though they are, are nearly always substantial
underestimates because, during the stress of a major epidemic, routine reporting
systems frequently break down. In addition, many patients with the septicaemic form
of meningococcal disease die before they reach a hospital or health center so that they
are never recorded in official statistics.
Figure 1.2. Annual number of meningitis cases, Burkina Faso, 1940-1993 (Source:
WHO 1998).
Seasonality
Epidemics nearly always start in the early part of the dry season when it is hot,
dry and dusty, build up to a peak at the end of the dry season, and then stop abruptly at
the onset of the rains, only to break out again during the following dry season (Moore
1992). As an example, Figure 1.3 shows t e number of hospital admissions for
meningococcal disease in Zaria, Nigeria from 1977 to 79, in relation to the absolute
humidity, the mean maximum temperature, and the presence of the Harmattan, a dusty
wind blowing from the Sahara.
The mechanisms underlying this seasonal association have never been clearly
defined. It is possible that droplet transmission is more efficient under conditions of
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low rather than high absolute humidity. This has never been properly investigated,
although one study found higher bacterial numbers in the air during the dry season
than during the rainy season (Ghipponi et al. 1971).  However, longitudinal carriage
studies conducted in the African meningitis belt showed that, in contrast to
meningococcal disease, ymptomatic carriage of meningococci was not seasonal
(Greenwood et al 1984) (Chapter 5).
Figure 1.3. Relation of seasonal climatic factors to hospital admissions for
meningococcal disease in Zaria, Nigeria, 1977-79 (Source: WHO 1998).
An alternative explanation for the seasonality of meningococcal disease in the
African meningitis belt has therefore been proposed (Greenwood 1999), in that
infections with the epidemic strain continue throughout the rainy season but that the
ratio of cases to asymptomatic carriers declines, thus resulting in an apparent
disappearance of the epidemic (Figure 1.4b).
CHAPTER 1. Introduction 7
Figure 1.4. Two alternative possible explanation for the seasonal pattern of
meningococcal meningitis in Africa. The line above the bars indicates the level of
transmission (Source: Gr enwood 1999).
Two pieces of evidence support this hypothesis. By means of repeated
nasopharyngeal swabbing, Blakebrough documented the spread of a serogroup A
meningococcus through a Nigerian village during the rainy season in the absence of
any cases of meningitis in this or in surrounding villages, although many cases
occurred in the n ighbourhood during the preceding and the following dry seasons
(Blakebrough 1979). The second piece of evidence comes from a study in The Gambia
in which a small number of sera were collected from children during a malaria survey
in the year preceding a major outbreak of serogr up A meningococcal disease in the
area (Greenwood et al. 1985). A rise in group A meningococcal antibody titre was
demonstrated in paired samples during the rainy season that preceded the outbreak,
Number of cases
a
b
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suggesting that the epidemic strain had already begun to circulate in the area without
causing clinical disease.
How might the ratio of asymptomatic carriers to clinical cases, usually at least
100:1, be changed by climate-associated factors? The simplest explanation is that the
extreme environmental conditions present at the end of the dry season – high
temperature, low absolute humidity and the Harmattan – damage the local mucosal
defenses so that the risk that these will be breached on exposure to a potentially
virulent meningococcus is enhanced (Greenwood 1999, Moore 1992). Other potential
factors that might be important for epidemics to develop are discussed below.
Serogroup
The major conventional classification of meningococci is based upon the
chemical structure of their capsular polysaccharide (Poolman t al. 1995). Thirteen
serogroups based on the antigenicity of these capsular polysaccharides are currently
recognized (Tikhomirov et al. 1997). Most meningococcal epidemics in Africa have
been caused by bacteria belonging to serogr up A. Although this serogroup used to be
the main cause of meningococcal disease in Europe and the USA, it has become very
rare since World War II (Cartwright 1995a). Serogroup B bacteria which are currently
the most frequent cause of m ningococcal meningitis in Europe and the USA has been
isolated only very rarely in Africa. In contrast, meningococci belonging serogroup C,
which are increasingly causing disease in Europe and the USA, have made an
important contribution to some epidemics in Africa (Broome t al. 1983, Whittle et al.
1975). Meningococci belonging to the rarer serog oup W135 have caused isolated
cases of meningitis in Senegal, Mali and The Gambia (Denis et l. 1982, Kwara et al.
1998). In 2000, serogroup W135 bacteria caused a major outbreak during the annual
Haj pilgrimage in Mecca. Serogroup W135 meningitis was subsequently reported
among a series of pilgrims returning from Saudi Arabia and their contacts (Popovic et
al. 2000, Taha et al. 2000).  Serogroup W135 disease has again been reported this year
(2001), among pilgrims attending the Hajj pilgrimage as well as among their contacts
(WHO 2001a). Serogroup X meningococci are even rarer than serogroup W135
bacteria and have caused only a limited number of sporadic meningitis cases (Chapter
3, Hansman 1983, Pastor e  al.1985, Ryan & Hogan 1980, Grahlow et al. 1986, Riou
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et al. 1996). However, sergroup X bacteria have the potential to cause outbreaks, as
was seen in Niger (Etienne t al. 1990, Campagne et al. 1999) and in Ghana (Chapter
5).
Meningococci belonging to an individual capsular polysaccharide serogroup can
be sub-classified on the basis of the antigenic characteristics of their outer membrane
proteins and lipopolysaccharides (Poolman et al. 1995), the electrophoretic mobility of
housekeeping enzymes (Wang et al. 1992) or by direct analysis of their DNA (see
below).
Causes of an epidemic
The factors that initiate African epidemics of meningococcal meningitis are not
understood. Epidemics are sometimes associated with the appearance of a new clone
but this is not always the case and, during epidemics, there may be an increase in cases
of meningitis caused by meningococci belonging to non-epidemic strains and even in
the incidence of cases of meningitis caused by the pneumococcus (Greenwood 1999).
This phenomenon suggests the importance of environmental factors. It is possible that
a new bacterial clone could be sufficiently antigenetically different from resident
meningococci to allow it to escape the background immunity induced by previous
asymptomatic nasopharyngeal infections. However, this has not been substantiated
clearly and the relative contribution of antibodies to the serogroup A capsular
polysaccharide, which is non-polymorphic, and of antibodies to the polymorphic outer
membrane protein antigens to naturally acquired protective immunity are not known
(Greenwood 1999). Accumulation of a population of non-exposed and hence non-
immune individuals through births and in-migration since the previous outbreak, and
loss of immunity in previously exposed individuals, are likely to be important
contributors to an epidemic (Moore 1992).
A striking feature of epidemic meningitis in Africa is that some communities
escape an outbreak, despite the fact that neighboring communities are affected
severely (Greenwood et al. 1987). One possible explanation for this phenomenon is
that protected communities are exposed to the epidemic strain during the rainy season,
as discussed above. An alternative explanation is the ‘2 hit’ theory w ich hypothesizes
that invasive disease is most likely to occur when exposure to a meningoc ccus occurs
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after infection with enteric bacteria that share antigenic-cross-reactivity with the
meningococcus (Griffiss 1982). IgA may block binding of IgG and IgM in this
situation and thus prevent complement activation. A third possible explanation is that
some kind of ‘first hit’ is needed to precipitate an African epidemic. In industrialized
countries, epidemics of influenza A seem to partially fill this role (Cartwright 1995b).
Predicting an epidemic
In Africa, epidemics of meningococcal disease are frequently not recognized
until they are well under way. Thus, control measures are often initiated too late to be
very effective. On the basis of data collected in Burkina Faso, Moore et al. (1992)
found that a weekly attack rate of more than 15 cases per 100,000 population collected
over 2 weeks was a sensitive and specific predictor of major epidemics of
meningococcal disease. This model was integrated into the WHO emergency-response
plan, which describes a strategy of using district-level surveillance to predict
epidemics and begin mass vaccination (WHO 1998). While retrospective analysis of a
data set collected in Ghana confirmed the usefulness of this threshold (Woods et al
2000), a data analysis from Niger supported an alternative threshold of 5 cases per
100,000 over 3 weeks (de Chabalier et al. 2000). This threshold-based approach to
epidemic prediction requires a good system of surveillance for cases of meningitis;
this is difficult to maintain during inter-epidemic periods when cases are few and
when control of other infections is a priority.
1.3 Treatment of meningococcal meningitis in Africa
Before 1938, there was no effective treatment for ening coccal disease in
Africa and the case fatality ratio was around 80% (Greenwood 1999). Serum therapy,
employed in Europe and the USA with modest success (Cartwright 1995a), was tried
in Africa but this was not a practical proposition in a tropical environment and
epidemic situations. The introduction of sulph namids in 1938 reduced mortality from
meningococcal meningitis to 10% or less (G e nwood 1999). However, sulphonamid-
resistant serogroup A meningococci began soon to be detected in several African
countries and by the early 1970s sulphonamids could no longer be used to treat
epidemic meningococcal disease. Today, a single injection of oily chloramphenicol is
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the standard treatment in countries were epidemic meningococcal meningitis occurs
(Greenwood 1999). However, appearance of meningococci resistant to
chloramphenicol has recently been reported in Vietnam (Gal mand et al. 1998).
1.4 Vaccines
Polysaccharide vaccines
In 1969, Gotschlich et al. (1969) described the development of highly
immunogenic serogroup A and C meningococcal vaccines based on purified
meningococcal capsular polysaccharides. The following year it was reported that a
serogroup C meningococcal polysaccharide vaccine gave a high degree of protection
against serogroup C meningococcal meningitis in American military recruits
(Artenstein et al. 1970) and a serogroup A polysaccharide vaccine was soon shown to
be equally effective in preventing serogroup A meningoccoal disease in Egypt
(Wahdan et al. 1973), the Sudan (Erwa et al. 1973), and Upper Volta (Ettori et al.
1977).  Subsequently, serogroup A + C meningocccal polysacchride vaccines have
been used extensively in Africa where they have been shown to be very effective at
bringing epidemics rapidly under control (Greenwood 1999). However,
meningococcal polysaccharide vaccines are poorly immunogenic in young children
and do not induce long-lasting, T cell-dependent immunological memory (Reingold et
al. 1985). Furthermore, meningococcal polysaccharide vaccines do not seem to reduce
the prevalence or incidence of nasopharingeal carriage of serogroup A or C
meningococci, as was found in studies conducted in Nigeria (Blakebrough et al. 1983)
and The Gambia (Hassan-King et al. 1988).
Polysaccharide / protein conjugate vaccines
In contrast to conventional polysaccharide vaccines, polysaccharide/protein
conjugate vaccines induce strong immunity also in young infants. Even more
importantly for the prevention of epidemic meningococcal disease, they induce T cell-
dependent immunological memory that is likely to be long lasting, especially if
boosted by exposure to naturally circulating bacteria (Greenwood 1999). On the basis
of experience with Hib and pneumococcal conjugate vaccines it is likely that
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meningococcal conjugate vaccines will also have some effect on nasophary geal
carriage.
An early trial of a meningococcal serogroup A + C conjugate vaccine (S lavo)
undertaken in The Gambia showed that the group C component of the vaccine was
immunogenic in young infants and that it induced imm nological memory (Leach et
al. 1997, Twumasi et al. 1995).  Unfortunately, the group A component of this vaccine
was not effective in inducing immunological memory. However, another serogroup A
+ C conjugate vaccine in which the meningococcal polysaccharides are coupled to
diphtheria toxin (Pasteur Mérieux) has given encouraging results during a pilot trial
conducted in Niger and a larger immunogenicity study of this vaccine is now
underway there (Greenwood 1999).
1.5 Bacterial population genetics and evolution
Whereas eukaryotic organisms have evolved mechanisms of sexual reproduction
in which extensive genetic recombination occurs as an integral part of propagation, he
bacteria reproduce asexually by binary fission, with each haploid mother cell giving
rise to two genetically identical daughter cells. In the absence of sexual processes,
chromosomal variation occurs by de novo mutations, which can spread only by being
passed on to the descendants of the cells in which they arose, and new lineages em rge
by the accumulation of such mutations over successive generations (Spratt & Maiden
1999). This transmission of genetic information can be regarded as ‘vertical’, as it
passes exclusively from mother to daughter cell. However, bacterial populations are
not entirely asexual since recombinational exchanges occur, mobilizing small genome
segments among li eages and species, a process that has been termed ‘localized sex’
(Maynard Smith et al. 1991). Localized sex disrupts clonal population structures by
providing a means of reassorting genetic variation, thereby enabling mutations to
escape the lineage in which they arose. This type of transfer of genetic information can
be regarded as ‘horizontal’, since genetic material is being moved between cells that
do not necessarily share a recent common ancestor (Spratt & Maiden 1999).  The three
most important mechanism of horizontal genetic exchange are co jugation,
transduction and transformation. Plasmids, prophages, transposons and insertion
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sequences can also be transferred horizontally, providing mechanisms for mobilizing
DNA among distantly related bacteria.
In the absence of the horizontal genetic exchange of chromosomal genes, a given
mutation will be associated with the other mutations that have accumulated in the
chromosome during the history of the lineage in which it arose. Consequently, the
distribution of chromosomal polymorphisms within an asexual (clonal) bacterial
population will be non-random, or in linkage disequilibrium (Spratt & Maiden 1999).
This contrasts with populations of sexual organisms where mutations are continually
reassorted, resulting in linkage equilibrium, i.e. mutations at different sites occur in
more or less random combinations.
In asexual bacterial populations, differences in the frequencies of particular
lineages will occur over time as a consequence of selection or stochastic events. When
mutations that increase fitness arise, the lin ages that contain them will increase in
frequency, resulting in the loss of other lineages, and this process (periodic selection)
reduces the genetic diversity within the population (Levin 1981). Similarly, bacterial
populations are subject to rapid expansions and severe bottlenecks which can also
reduce the diversity of clonal populations (Achtman 1995a).
The relative contribution of recombination, as opposed to de novo mutation, in
the generation of new bacteria genotypes varies among bacterial populations (Spratt &
Maiden 1999), and as this contribution increases, the clonality of a given population
decreases. A spectrum of population structures can be observed, reaching from the
extremes of strictly c onal (e.g. Salmonella enterica, Boyd et al. 1996), where
apparently no recombination has occurred in the evolutionary history of the species, to
non-clonal, or ‘panmictic’ (e.g. Helicobacter pylori, Go et al. 1996), where
recombinational exchanges are sufficiently frequent to randomize the alleles in the
population and to prevent the emergence of stable clones. Most bacterial populations
occupy a middle position where recombination is highly significant in the evolution of
the population, but is not sufficiently frequent to prevent the emergence of clonal
lineages. A mixture of non-cl al and clonal elements within populations of
recombinogenic bacterial pathogens may often be related to differences in their
ecology and epidemiology (Spratt & Maiden 1999).
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The term ‘epidemic clonal’ has been used to describe a situation, where a
particularly effective lineage within a basically non-lonal bacterial population arises
and rapidly spreads, so that, in the short term, a large number of related organisms
come to predominate the population (M ynard Smith et al. 1993,  Maynard Smith et
al. 2000). This phenomenon is particularly clear where the emerging lineage has
increased capacity to cause disease, as the analysis of isolates obtained exclusively
from disease can result in a large amplification of the significance of the epidemic
clone as a consequence of sampling bias (see below). In most cases, analysis of the
small fraction of isolates that are from disease will underestimate the diversity of the
population as a whole and will overestimate the extent of clonality in the population. It
is possible for all three types of structure, clonal, panmictic and epidemic clonal, to be
present in a single bacterial species (Spratt & Maiden 1999).
1.6 The genetic population structure of Neisseria meningitidis
The genetic population structure of N. meningitidis  considered weakly clonal
(Spratt & Maiden 1999). This organism illustrates the sampling problems associated
with some bacterial pathogens. Asymptomatic nasopharyngeal carriage of N.
meningitidis  common and only very occasionally do the bacteria invade the blood
stream and cerebrospinal fluid to cause disease (Cartwright 1995b). Populations of the
meningococcus are highly diverse (Caugant et al. 1987), comprising many different
genotypes, the majority of which are rarely isolated from patients with invasive
disease (Caugant et al. 1988). Carried N. meningitis recombine extensively (Jo ley et
al. 2000), and it has been estimated that an individual nucleotide site in a
meningococcal housekeeping gene is at least 80 times more likely to change by
recombination than by point mutation (Feil et al. 1999). Furthermore, analysis of
houskeeping genes showed non-congruence between gene trees (Feil t al. 2001). All
this evidence supports a population structure which is basically non-clonal.
A few hyperinvasive lineages within serogroup B and C meningococci (ET-5
complex, ET-37 complex, lineage III and cluster A4) are responsible for most of the
cases of meningococcal disease in many parts of the world (Caugant 1998). An
‘epidemic lonal’ population structure has been attributed to these lineages, based on
the fact, that levels of linkage disequilibrium were low when corrections for sample
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bias were made (Maynard Smith et al. 1993). In contrast, the clonal groupings
identified within serogroup A meningococci, which have been responsible for most of
epidemic disease in Africa (A htman 1995b), seem to be more clonal (Bart et al.
2001).
The ability to identify accurately the bacterial strains that cause disease is central
to epidemiological surveillance and public health decisions concerning. Molecular
typing methods are used to address two very different kinds of problems (Spratt &
Maiden 1999). The first are short-term or local epidemiological questions, i) are the
isolates recovered from a localized outbreak of disease largely identical or diverse, or
ii) is relapse of disease after intervention due to treatment failure or re-infection? The
second type of problem concerns long-term or global epidemio ogy, e.g. how do
strains causing disease in one geographical area relate to strains recovered worldwide?
1.7 Rationale and research frame work
One of the major problems related to meningococcal disease in the African
meningitis belt is that the factors precipitating epidemics are largely unknown.
Epidemics are therefore very unpredictable, which usually leads to control measures
like mass immunizations being initiated too late to be effective.
In an attempt to address some of the problems related to epidemic
meningococcal disease in Africa, and following a major epidemic that occurred in
Northern Ghana in 1997 (Tikhomirov et al. 1997) a scientific research partnership was
initiated between the Swiss Tropical Institute (STI) and the Navrongo Health Research
Center (NHRC). Within this collaboration, several research questions relevant to the
epidemiology of meningococcal meningitis in Ghana were addressed. The molecular
epidemiological aspects of these collaborative research efforts are presented in this
thesis.
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2.1 Goal
To contribute to the understanding of the epidemiology of meningococcal
meningitis in Africa using conventional and molecular epidemiological techniques.
2.2 Objectives
1 To determine the causative agents of bacterial meningitis in the Kassena-
Nankana District (KND) of Northern Ghana.
2 To investigate the dynamics of meningococcal carriage in the KND by
analyzing the persistence of epidemic strains and the acquisition of new
clones.
3 To study the influence of Neisseria lactamica on the dynamics of
meningococcal carriage in the KND.
4 To analyze the genetic population structure and micro-evolution of the
meningococcal strains dominating in the KND by comparing them to strains
recovered over the last decades in different countries of Africa, Europe and
North America.
5 To determine the genetic diversity of non-serogroupable N. meningitidis
isolated in the KND and to compare them to the dominating encapsulated
strains in the district.
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3.1 Abstract
During a meningitis outbreak in the eastern sub-district of the Kassena-Nankana
District of the Upper East Region of Ghana, we analyzed cerebrospinal fluid from
suspected meningitis cases for the most common causative organisms. In 50 of 92
samples analyzed, serogroup A Neisseria meningitidis were detected. The ages of
serogroup A N. meningitidis patients ranged from 4 months to 64 years. The case
fatality ratio was 20%. Coma or stupor on presentation worsened the prognosis. All
serogroup A N. meningitidis i olates recovered revealed the A: 4: P1.9, 20 phenotype
characteristic for the subgroup III clonal grouping. No evidence for resistance to
penicillin G, chloramphenicol, cefotaxime, ciprofloxacin, rifampicin or tetracycline
was found. All strains were resistant to sulfadiazine. Restriction analysis patterns of
opa, iga and ingA genes were characteristic for the majority of N. meningitidis
serogroup A subgroup III bacteria isolated in Africa after the 1987 epidemic in Mecca.
Differences in pulsed-field gel electrophoresis patterns of NheI and SpeI digested
DNA revealed micro-heterogeneity among the Ghanaian isolates.
3.2 Introduction
Meningococcal meningitis remains an important global health problem. While
levels of endemic infection are high in many communities throughout the world,
epidemics have been observed since World War II predominantly in a number of
developing countries, including China, Brazil, and various sub-Saharan African
nations (WHO 1998). In the savanna region of sub-Saharan Africa called the
‘Meningitis Belt’, epidemic waves of meningococcal disease have recurred every 8 -
12 years since at least the beginning of the 20th century (Achtman 1990, Moore 1992).
Effective surveillance and early warning systems are essential for the planning and
implementation of mass vaccination campaigns to control epidemics. However, the
factors precipitating these epidemics and the transition from an endemic situation are
not well understood.
While endemic infections are usually caused by meningococci belonging to
serogroups B and C, most large epidemics are caused by serogroup A strains. Random
endemic N. meningitidis olates are diverse and do not exhibit a clonal population
structure. In contrast, meningococci causing epidemics belong to fairly uniform clonal
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groupings (Achtman 1995b), i.e., they are the descendants of a common ancestor.
Clonal analyses of serogroup A meningococci from epidemic waves have identified 9
clonal groupings, designated I-III, IV-1, IV-2, and V-VIII (Wanget al. 1992).
Methods of molecular epidemiology, which use natural genetic variation as the basis
of classification (i.e. multilocus enzyme electrophoresis (MLEE), the random
amplified polymorphic DNA (RAPD) method and multilocus sequence typing
(MLST)) have demonstrated that bacteria belonging to a certain clonal grouping are
largely uniform in many independent genetic properties (Maiden t al. 1998).
Microevolution, which seems to be largely associated with horizontal genetic
exchange, is responsible for some diversity within subgroups (Morelli et al. 1997).
In 1987 subgroup III serogroup A meningococci caused an outbreak in Mecca
during the annual H jj pilgrimage (Moore et al. 1988). These bacteria had never been
isolated before in Africa, but were previously associated with 2 pandemic waves
affecting China, northern Europe and Brazil in previous decades (Achtm n 1995b).
Meningococci descended from those of the Mecca outbreak can be distinguished from
pre-Mecca strains by RFLP and post-Mecca bacteria have caused multiple epidemics
of meningococcal disease throughout the African meningitis belt since 1988 (Achtman
1995b, Morelli et al. 1997).  The first subgroup III African epidemics were in
Ethiopia, Chad and Sudan in 1987-1989. In the 1990s the epidemic wave spread to the
rest of Africa, including Niger (more than 25,000 cases notified in 1995, more than
16,000 cases in 1996), Northern Nigeria (more than 105,000 reported cases in 1996),
Burkina Faso (more than 40,000 reported cases in 1996, more than 20,000 in 1997)
and Mali (more than 7,000 reported cases in 1996, more than 10,000 in 1997).
In the dry season between November 1996 and May 1997 an epidemic occurred
in Northern Ghana. A total of 18,799 meningitis cases with 1,352 deaths were
reported. 1200 of these cases and 67 deaths were in the Kassena-Nankana District
(Upper East Region) (Enos 1997).  We now report analyses of cerebrospinal fluid
from suspected meningitis cases from a smaller outbreak in this district one year later.
In the majority of cases we found serogroup A meningococci, which were
indistinguishable by whole cell ELISA and RFLP from the post-Mecca subgroup III
bacteria. We also used pulsed-field gel electrophoresis to investigate further
microevolution. Our results reconfirm that within one decade subgroup III has spread
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from Mecca through numerous Eastern and Central African countries to West Africa.
We present some evidence for further diversification.
3.3 Materials and Methods
Study area and population
The study was conducted in the Kass na-Nankana District (KND) of the Upper
East Region of Ghana. The district lies within the guinea Savannah woodland area of
Ghana with a population of 140,000 and has two main seasons; a short wet season
from June to September and a long dry season for the rest of the year. The general
population is rural except for those living in the small town of Navr ngo, which has a
population of about 20,000.
From February to April 1998, a small meningitis outbreak occurred in the
eastern sub-district of KND. During this outbreak, all suspected meningitis cases
presenting at the War Memorial Hospital (WMH), Navrongo or at one of the three
health centers in the KND were recruited. History and vaccination status were
determined using a standardized questionnaire and a clinical examination performed
on all the patients. A lumbar puncture was done before treatment and the cerebrospinal
fluid (CSF) specimen sent to the laboratory of the WMH. Antibiotic treatment was
started immediately after the lumbar puncture. All the patients were treated with
chloramphenicol, crystalline penicillin and chloroquine according to the standard
treatment protocol of the Ghanaian Ministry of Health.
Characterisation of bacteria
Boiled CSF supernatants were tested serologically (Slidex méningite-Kit, Bio-
Mérieux) for capsular polysaccharide antigens of N. meningitidis ( erogroups A, B and
C), Haemophilus influenzae type b and Streptococcus pneumoniae. CSF specimens
were frozen at -70oC and transported to Switzerland on dry ice for further
microbiological analyses.
For the cultivation of bacteria, CSF specimens were inoculated on blood,
chocolate and Thayer-Martin agar (Thayer & Martin 1966) and incubated for 24h at
37oC in an atmosphere of 5% CO2. Isolates were stored in 10% skim milk (Difco) on
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glass beads at -70oC. All bacteria strains isolated from Thayer-Martin agar were
identified as meningococci by Gram’s stain morphology, cyt chrome oxidase test
using N,N,N’,N’-tetramethyl-1,4-phenylene-diammoniumdichloride (Merck,
Darmstadt) as substrate, glucose, maltose and sucrose utili ation in cystine-trypticase
agar (BBL, Heidelberg) and gamma-glutamyltransferase activity (MPR 1-Kit,
Boehringer Mannheim). The Gram-negative rods isolated from blood and chocolate
agar were identified with api 20E (Bio-Mérieux, Nürtingen), the Gram-positive cocci
showing a-hemolysis by testing for Optochin sensitivity (DD1 discs, Oxoid, Wesel).
H. influenzae was characterised by growing only on chocolate agar or as satellite
colonies on blood agar with a Staphylococcus aureus streak and X- and V-factor
requirements (V-, X+V-discs, Oxoid, Wesel).
All isolated meningococci were serogrouped/typed/subtyped with monoclonal
antibodies by whole cell ELISA according to procedures previously described (Wang
et al. 1992). One N. meningitidis serogroup X strain could not be serogrouped by
whole cell ELISA because of lack of the appropriate monoclonal antibody.
Serogrouping was done by slide agglutination in this case using erogroup X specific
antiserum (Murex).
The N. meningitidis isolates were tested for sensitivity to penicillin G,
cefotaxime, ciprofloxacin, rifampicin, chloramphenicol, tetracycline and sulfa iazine
by the E-test method (AB Biodiscs, Solna, Sweden) according to the manufacturer’s
instructions.
For restriction fragment length polymorphism (RFLP) analyses, me ingococcal
chromosomal DNA was isolated as described previously (Sarkari et al. 1994).
Serogroup A meningococci were tested for opa, iga and ingA alleles as described
(Morelli et al. 1997). Two N. meningitidis serogroup A subgroup III control strains
were incorporated, one 'pre-Mecca' strain (Morelli et al. 1997) isolated in China in
1966 (strain Z3906) and one 'post-Mecca' strain isolated in Chad in 1988 (Z3524). For
pulsed-field gel electrophoresis (PFGE), meningococcal DNA was prepared in agarose
blocks as described by Morelli et al. (1997). The DNA was digested with NheI and
SpeI and resolved by pulsed-field gel electrophoresis (Morelli et al. 1997). After
electrophoresis, the gels were stained with thidium bromide, visualized on an
ultraviolet light transilluminator and photographed.
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All CSF samples that remained culture negative were tested for the content of
meningococcal DNA by IS1106 PCR according to previously described procedures
(Newcombe t al 1996). The detection of the PCR products was done with a DNA
enzyme immunoassay kit (GEN-ETI-K DEIA, iaSorin). PCR products were directly
sequenced in both directions using the ABI Prism 310 Genetic Analyzer (Perkin
Elmer, Foster City, CA). Culture and IS1106 PCR negative CSFs w re tested for
Herpes simplex virus, Varicella-zoster virus and enteroviruses by PCR as described
previously (Aurelius et al. 1991, Puchthammer-Stökl 1993, Romero & Rotbart 1993).
Statistical methods
Log-linear analysis of contingency tables was used to investigate possible
associations between NheI and SpeI variant patterns, and Wilcoxon tests were used to
compare the median times of occurrence these patterns. Fisher’s exact tests were used
to identify prognostic factors for the outcome.
In order to identify a possible spatial clustering of the isolates with distinct
PFGE patterns, euclidean distances were calculated between the homes of each
possible pair formed from these cases. For each restriction enzyme the 231 pairs were
classified according to whether the members of the pair both belonged to the same
PFGE pattern. The mean distances between members of these hom typic pairs were
compared with the mean distances between members of heterotypic pairs. A
randomisation test (Manly 1991) was used to test whether there was a statistically
significant difference between these two means.
3.4 Results
Meningitis cases
From the 14th of February, 1998 to the 24th of April, 1998, a total of 92
suspected meningitis cases were recruited at the WMH and at the Eastern Health
Centre of the KND. 50 patients (52% males) were diagnosed as having meningococcal
meningitis of serogroup A. Bacteria were cultivated and characterized in detail from
36 CSF samples. Latex-agglutination and/or IS1106 PCR ELISA revealed serogroup
A polysaccharide antigen and me ingococcal DNA, respectively in another 14 cases
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where no bacteria could be cultivated. Of the remaining 42 suspected meningitis cases,
one was diagnosed as having a X: NT: P1.5 N. meningitidis phenotype, one
Streptococcus pneumoniae, two Haemophilus influenzae type b and one Enterobacter
aerogenes meningitis. CSFs from patients without confirmed bacterial meningitis were
tested by PCR for the presence of Herpes simplex virus, Varicella-zoster virus and
enteroviruses. However none was positive. 37 (40.2%) of all suspected meningitis
cases thus remained without any confirmed diagnosis. Among these cases, 9 CSF
were turbid, indicating probable bacterial infection. Table 3.1 shows the distribution of
meningitis cases by etiology and method of diagnosis.
The median age of the 50 patients with serogroup A meningococcal meningitis
was 8 years (mean=10, range 4 months to 64 years). 19 were less than 5 years with 4
patients being less than one year old, 12 were between 5 and 9 years, 16 between 10
and 19 years, and 3 were over 20 years. 10 (20%) of these patients died during
hospitalization. Clinical information on admission, and histories were available for 34
patients (68%) (Table 3.2).  All these patients had a history of fever, most of them
lasting for one day only. Three-quarter received drugs prior to admission, usually
antimalarials.   On clinical examination most of them had neck stiffness and one
quarter presented with stupor or coma. The latter was associated with death or
sequelae (odds ratio=6.6, CI95%: 1.3-33.3, p=0.03) but there was no significant
association between the outcome and any other variable recorded at admission (Table
3.2). Out of the 5 additional confirmed bacterial meningitis cases, three died during
hospitalization (N. meningitidis serogroup X, H. influenzae, E. aerogenes).
Table 3.1.  Diagnosis of meningitis cases
Causative agent n % of cases Diagnosed by
Latex-Agglutination, culture, biochemistry, ELISA (72%)
Latex-Agglutination, IS1106 PCR ELISA (18%)
Neisseria meningitidis  serogroup A 50 54
IS1106 PCR ELISA (10%)
Neisseria meningitidis serogroup X 1 1 Culture, biochemistry, slide agglutination, ELISA
Streptococcus pneumoniae 1 1 Latex-Agglutination, culture, Optochin sensitivity
Enterobacter aerogenens 1 1 Culture, biochemistry (api 20E)
Haemophilus influenzae
 type b
2 2 Latex-Agglutination, culture, slide agglutination (50%)
Latex-Agglutination (50%)
No conf. Diagnosis; turbid CSF 9 10 --------
No conf. Diagnosis; clear CSF 28 30 --------
Total 92 100
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Table 3.2.  History and clinical examination findings in the serogroup A
meningococcal meningitis cases.
Condition
All cases
n=34 (%)
Death or sequelaea
n=9 (%)
History
    Fever 34/34 (100) 9/9 (100)
       Duration (1 day vs more) 17/34 (50) 5/9 (56)
    Headache 21/26b (81) 6/9 (67)
    Nausea 4/26b (15) 1/9 (11)
    Vomiting 28/34 (82) 6/9 (67)
    Neck pain 17/28b (61) 4/9 (44)
    Neck stiffness 18/34 (53) 6/9 (67)
    Convulsions 10/34 (29) 5/9 (56)
    Altered consciousnessc 8/34 (24) 3/9 (33)
    Prior drug intake 26/34 (76) 7/9 (78)
        Antimalarials 16/34 (47) 2/9 (22)
        Antibiotics 5/34 (15) 2/9 (22)
    Vaccinated 21/32d (66) 5/7d (71)
Clinical examination
    Temperature > 37.5o C 22/33e (67) 3/8e (38)
    Temperature > 39.0o C 4/33e (12) 1/8e (13)
    Neck stiffness 28/34 (82) 7/9 (78)
    Altered consciousnessf 9/34 (26) 5/9 (56)
a One case of sequelae (deafness), b Denominator is less due to non-applicable
variable, c Drowsiness or loss of consciousness, d Two missing values, e One missing
value, f Stupor or coma.
Characteristics of serogroup A meningococcal isolates
All the 36 strains serotyped by whole cell ELISA were A: 4: P1.9, 20
meningococci which corresponds to subgroup III (Wang et al. 1992). Three were
tested by MLST, all were ST5, typical of subgroup III (Maiden et al. 1998). No
evidence for resistance to penicillin G, chloramphenicol, cefotaxime, ciprofloxacine,
rifampicine or tetracycline was found. All strains were resistant to sulfadiazine
(minimal inhibitory concentration MIC >256mg/ml). All strains included in the RFLP
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analysis of opa, iga and ingA alleles showed the pattern expected for post-Mecca sub-
group III (Table 3.3). As an example the DdeI r striction fragment pattern of the 413
bp opaD 100 amplification product is shown in Figure 3.1.
Figure 3.1. Restriction fragment length polymorphism analysis of opaD PCR
products from enigococci from Ghana. A molecular weight marker was loaded in the
flanking tracks as indicated (M). The 413 bp opaD 100 amplification product was
restricted by DdeI. Two fragments (128 and 285 bp) were obtained with all strains
including the post-Mecca control strain Z3524 (track 13) isolated in Chad in 1988 and
several post-Mecca control strains (tracks 1, 3, 5, 7, 9 and 11) isolated in The Gambia in
1997. As expected, the PCR product of the pre-Mecca control strain isolated in China in
1966 (Z3906) was not cut by DdeI (track32).
Table 3.3. RFLP analysis of paA, opaB, opaD, ingA and iga alleles: Size of the DNA fragments expected for serogroup A, post-Mecca
subgroup III meningococci. Pre-Mecca strains have opaD131, opaB92, ingA1 and iga1 or iga2. Post-Mecca strains have opaD100, opaB94,
ingA2 and iga3. The restriction tests shown here distinguish between these various alleles.
pre-Mecca post-Mecca
Gene / segmentRestriction
endonuleases
Size of expected
PCR product (bp)
Sizes of expected
restriction fragments (bp)
Size of expected
PCR product (bp)
Sizes of expected
restriction fragments (bp)
opaA 132 RsaI 418 56, 179, 183 418 56, 179, 183
opaA 132 HpaII 418 7, 126, 285 418 7, 126, 285
opaB 92 HincII 461 164, 297 no product ----
opaB 94 BanI no product ---- 461 198, 263
opaD 100 DraI 413 179, 234 413 179, 234
opaD 100 DdeI 413 413 413 128, 285
ingA NheI 350 350 350 100, 250
iga DdeI 2009 2009 2009 535, 1474
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For PFGE analysis, DNA was digested with the rare cutting enzymes Nh I and
SpeI. The results (Figures 3.2a & 3.2b) showed that the isolates from Ghana resembled
post-Mecca strains which have lost one NheI band and gained 2 others relative to pre-
Mecca bacteria. In addition, several polymorphic sites were seen, that subdivided the
bacteria although all are very closely related. Three distinct patterns were
distinguishable with each of the two restriction enzymes among the Ghanaian isolates.
Based on the few polymorphic sites, there was no association between the NheI a d
SpeI variant patterns (likelihood ratio from log-linear model c42 = 4.2, p= 0.4). A total
of 7 combinations of the N I and SpeI variant patterns were found. From the map
showing the spatial distribution of the 32 cases where the position of the home was
geocoded (Figure 3) it was not clear whether these bacterial types were clustered in
space. However, the randomization test indicated that the observed degree of
clustering of homotypic cases could easily have been due to chance (Table 4). The
median times of occurrence of the different types distinguished by either N I or Sp I
restriction analysis were not significantly different (Wilcoxon tests: c22=2.0; P=0.4
and c22=1.1; P=0.6, respectively, Table 5).
Table 3.4. Analysis of spatial clustering of PFGE restriction types.
Restriction
enzyme
N of homogeneic
pairs
N of heterogeneic
pairs
Difference between
mean distancesa (km)
p-valueb
NheI 221 185 -2.2 0.092
SpeI 196 210 -1.3 0.42
Both 117 289 -1.3 0.27
a Mean distance between homogeneic pairs minus mean distance between
heterogeneic pairs, b From randomisation test .
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Table 3.5. Median times to occurrence of different PFGE restriction types.
Frequency Median date
NheI-type 1 10/31* (32%) 08/03/98
2 20/31 (65%) 12/03/98
3 1/31 (3%) 08/04/98
SpeI-type 1 5/31 (16%) 13/03/98
2 20/31 (65%) 14/03/98
3 6/31 (19%) 17/03/98
* Data from 5 strains out of 36 were not available.
Figures 3.2a & 3.2b. Pulsed-field gel electrophoresis of DNA from
meningococci from Ghana. Samples were loaded in tracks 1 to 36 in the following
order (track: strain): 1: Z3906 (pre-Mecca control strain); 2: Z3524 (post-Mecca
control strain); 3: Z7057; 4: Z7058; 5: Z7059; 6: Z7060; 7: Z7061; 8: Z7062; 9:
Z7063; 10: Z7064; 11: Z7065; 12: Z7066; 13: Z7067; 14: Z7068; 15: Z7069; 16:
Z7070; 17: Z7071; 18: Z7072; 19: Z3906; 20: Z3524; 21: Z7073; 22: Z7074; 23:
Z7075; 24: Z7076; 25: Z7077; 26: Z7078; 27: Z7079; 28: Z7080; 29: Z7081; 30:
Z7082; 31: Z7083; 32: Z7084; 33: Z7085; 34: Z7086; 35: Z7087; 36: Z7088; (strains
Z7090, Z7092 and Z7093 not shown; one isolate out of 36 was not analysed by
PFGE). Molecular weight markers were loaded in the flanking tracks as indicated
(LM: Low Range Marker; MM: Mid Range Marker I); their molecular weights are
indicated at the left. Differences in the PFGE patterns are indicated with arrows at the
right. The 3 different PFGE restriction types found with each of the two enzymes are
indicated in roman numbers (X: pre-Mecca control strain; Y: post-Mecca control
strain). a) digested with NheI. b) digested with SpeI.
(a)
23
48
97
145
194
(b)
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Figure 3.3. Spatial distribution of the 7 combined PFGE types (NheI+SpeI) in the
Kassena-Nankana East sub-district. PFGE patterns of 35 isolates were analysed and
the homes of 32 of the corresponding cases were traced. The 7 PFGE combination
types were: type 1: NheI-II+SpeI-II; type 2: NheI-I+SpeI-II; type 3: NheI-II+SpeI-III;
type 4: NheI-I+SpeI-I; type 5: NheI-II+SpeI-I; type 6: NheI-I+SpeI-III; type 7: NheI-
III+SpeI-III. Two type 1 cases occurred in one compound.
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3.5 Discussion
The clinical picture of meningitis in the 1998 epidemic in Kassena-Nankana
district was typical of that for outbreaks in the meningitis belt. There was a 20% case
fatality rate, which was higher than the expected 5-10% (WHO 998). This probably
reflects delays in arrival at the health facilities, but not resistance of the bacteria to the
antibiotics used. The patients who presented with coma or stupor had particularly poor
prognosis, but there was no association between the duration of fever prior to
admission and outcome.  When considering these prognostic factors however, the
reader should bear in mind the low statistical power of analyses based on only eight
deaths and one case with deafness.
We could demonstrate no cases of viral etiology or resistance of meningococci
to antibiotics other than sulphadiazine. It is not clear whether there was an increase in
the incidence of S. pneumoniae and H. influenzae meningitis during the outbreak. Due
to the 1997 epidemic the population was clearly attuned to the danger of meningitis,
and many cases (29/50, 58%) were reported by relatives to have been vaccinated with
an A and C bivalent polysaccharide vaccine during late 1997 and early 1998.  This
does not necessarily reflect a low efficacy of the vaccine: a major effort was made to
ensure high coverage, so far more vaccinated than unvaccinated individuals were at
risk in the population. The epidemic would probably have been much larger without
this vaccination campaign.
The latex agglutination method missed 5/50 cases of meningococcal meningitis
which were detected using the IS1106 PCR ELISA. The specificity of IS1106 PCR
ELISA has been questioned (Borrow et al. 1998), but in our setting, where A
meningococci were dominant, this technique is probably reliable. Furthermore, the
sequences of the PCR products obtained from the 5 latex agglutination negative cases
were identical to those of subgroup III serogroup A controls and differed from
serogroup B and C controls (data not shown). All latex positive samples were also
PCR positive. Among the patients who remained without confirmed diagnosis, 9 had a
turbid CSF, making them probable bacterial meningitis cases. Some of the patients
without confirmed diagnosis and with clear CSF may have had underlying diseases
other than meningitis.
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Overall, the stability of the genome of the post-Mecca subgroup III clone of N.
meningitidis allows clear assignment a decade after its origin. However uptake and
insertion of foreign DNA have been documented in these bacteria (Morelli et al.
1997). The PFGE results are comparable to those observed from other countries where
subgroup III has been analyzed (unpublished data). The statistical analysis of possible
clustering of cases caused by PFGE identical strains showed that these were not
significantly closer together than cases caused by PFGE different pairs.  Although the
sample size (and hence power) was limited, this is evidence that the variants did not
spread out in the course of the 1998 outbreak from point sources within the area, and
suggests that transmission between cases during 1998 was not an important cause of
the outbreak. The genetic heterogeneity in our isolates and the absence of a temporal
pattern in the PFGE types also suggest that the outbreak arose from pre-existing
heterogeneous populations of subgroup III bacteria, provoked by a common
environmental stimulus.  Some genotypes appear to be distributed predominantly at
the western side of the map, others occur in broad bands down the center, and others
towards the north.  These patterns could be non-random in space, without leading to
evidence of clustering in our randomization test.   The patterns are consistent with the
different bacterial genotypes entering Kassena-Nankana before the start of the 1998
outbreak in temporal waves or from different directions.
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4.1 Abstract
The genetic variability at six polymorphic loci was examined within a global
collection of 502 isolates of subgroup III, serogroup A Neisseria meningitidis. Nine
“genoclouds” were identified, consisting of genotypes that were isolated repeatedly
plus 48 descendent genotypes that were isolated rarely. These genoclouds have caused
three pandemic waves of disease since the mid-1960’s, the most recent of which was
imported from East Asia to Europe and Africa in the mid-1990s. Many of the
genotypes are escape variants, resulting from positive selection which we attribute to
herd immunity. Despite positive selection, most escape variants are less fit than their
parents and are lost due to competition and bottlenecks during spread from country to
country. Competition between fit geno ypes results in dramatic changes in population
composition over short time periods.
4.2 Introduction
Epidemic meningitis has posed a major health problem since it was first
recognized in 1805 (Vieusseux 1806). Epidemics have recurred approximately every
10 years in this century within the African “meningitis belt” of sub-Saharan Africa
(Lapeyssonnie 1963, Caugant 1998, Achtman 1990) and until the mid-1980’s within
China (Wang et al. 1992). Epidemics in other geographical areas are more sporadic
and in recent decades, only few industrialized countries have suffered from large
epidemics (Caugant 1998), with the notable exceptions of Norway and New Zealand.
Historically, most large epidemics of meningitis were caused by Neis ria
meningitidis that express the serogroup A capsular polysaccharide. Most recent
epidemics have been caused by two pandemic waves (Achtman t al. 1992) of the
clonal grouping of serogroup A bacteria that is called subgroup III (Wang et al. 1992,
Maiden et al. 1998). The first pandemic wave affected China (mid-1960’s), northern
Europe (Russia and the Scandinavian countries; 1969-mid 1970’s) and Brazil (mid-
1970’s). A second subgroup III pandemic wave began in China and Nepal in the early
1980’s, followed by an epidemic during the annual Hajj pilgrimage to Mecca, Saudi
Arabia of 1987. Pilgrims returning from Mecca distributed subgroup III meningococci
to most countries of the globe (Achtman et al. 1992, Moore et al. 1988). Subgroup III
has subsequently caused numerous epidemics throughout Africa (Ca gant 1998,
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Nicolas et al. 2001); in 1996, 150,000 cases of meningococcal disease were reported
from Africa (Tikhomirov et al. 1997), most caused by subgroup III (Caugant 1998).
Subgroup III meningococci are so uniform that only few genetic variants have
been revealed by MLEE (multi-locus enzyme electrophoresis) (Wang t al.1992, 
Achtman et al. 1992), RAPD (random amplified polymorphic DNA) (Bart et al. 1998,
Achtman et al. 2001) or MLST (multi-locus sequence typing) (Maiden et al. 1998, 
Achtman et al. 2001). Such variants can arise during co-colonization of the
nasopharynx with other N. meningitidis and related species due to the import of genes
by DNA transformation (Li z et al. 2000, Smith et al. 2000).
The availability of hundreds of subgroup III strains isolated in different
countries since the mid-1960’s provided an opportunity to elucidate important features
of bacterial microevolution. We have used a multilocus approach involving sequence
variability at six polymorphic loci to elucidate the molecular epidemiology of
subgroup III bacteria. These six loci encode three outer membrane proteins (opaB,
opaD, tbpB), one secreted protein (iga), one housekeeping protein (pgm) and one
defective IS element (IS1106A) and were chosen due to their relatively high degree of
polymorphism in subgroup III. Previous work has shown that differences at the opaB,
opaD and iga loci (that encode opacity adhesins and IgA1 protease) distinguish
bacteria isolated during the first pandemic wave or at the beginning of the second
pandemic wave from those isolated since 1987 from Mecca pilgrims and in Africa
(Morelli et al. 1997). The pgm gene encoding phosphoglucomutase differentiates
subgroup III isolates of MLST sequence types 5 through 7 (Maidenet al. 1998). tbpB
(transferrin-binding protein B) differed between older and newer isolates from
Moscow (Achtman et al. 2001). IS1106A is a defective IS element that is inserted
upstream of the opcA locus (Zhu et al. 1999) and was shown by preliminary
experiments to be polymorphic in subgroup III.
The results show that successive waves of pandemic spread are associated with
genoclouds of genetic variants, each containing a particularly fit, dominant genotype.
Furthermore, the recent evolution of a new genocloud has now resulted in a third
pandemic wave of disease.
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4.3 Materials and Methods
Bacterial strains
502 subgroup III strains isolated between 1966 and 2000 were tested. The
countries and detailed dates of isolation have been described for 314 strains (1966–96)
from diverse global sources (Morelli et al. 1997) and 29 ST7 strains (1995–99) from
Africa (Nicolas et al. 2001). 159 additional isolates were from epidemics in Chad
(1988, 9 strains), The Gambia (1997, 54), Ghana (1997-1998, 39) (Chapter 3),
Mongolia (1994-95, 10) (Malorny et al. 1998), Moscow (1969-77, 8; 1994-97, 21)
(Achtman et al. 2001) and Sudan (1988, 14) and from endemic disease in the UK
(1997-2000, 4). The assignment of these additional isolates to subgroup III is based on
MLEE for isolates from Chad, Sudan and Mongolia, RAPD for isolates from Moscow
(Achtman et al. 2001) and by the possession of strongly related PFGE patterns with
two restriction e donucleases (Chapter 3) for isolates from The Gambia, Ghana and
the UK. Of the 502 isolates, 60 have been shown to belong to the MLST sequence
types ST5 to ST7 that are characteristic of subgroup III (Nic las 2001, Achtman et al.
2001). Most of the strains have been serogrouped, serotyped and serosubtyped by
ELISA using monoclonal antibodies and are A:4,21:P1.9,20, as is typical of subgroup
III (Wang et al. 1992).
Sequencing and accession numbers
Independent PCR products from each locus were sequenced from both DNA
strands using automated cycle sequencing (ABI 377) with dRhodamine-labelled
terminators (PE Applied Biosystems). Sequences of IS1106A elements have been
deposited under AJ276902-AJ276908 and AJ292239. Sequences of tbpB all les have
been deposited under AJ276909-AJ276937. Other sequences have been described
elsewhere (Maiden et al. 1998, Morelli et al. 1997, Malorny et al. 1998) (GenBank
AJ292235-AJ292238).
RFLP typing
All 502 isolates were tested for restriction fragment length polymorphism
(RFLP) at six loci (pgm, iga, opaB, opaD, IS1106A and tbpB) as described (Achtman
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et al. 2001, Morelli et al. 1997). In addition, all variant alleles were sequenced from
representative strains (pgm, 60 strains; iga, 18; opaB, 43; opaD, 50; IS1106A, 21;
tbpB, 35). The sequence variability at iga, opaB and opaD has been described
elsewhere (Morelli et al. 1997). Details of the sequence variability at IS1106A are
presented in the supplemental data (www.pnas.org). The RFLP analysis of pgm
distinguishes pgm3 from pgm19, but not from pgm11 which only differs by one
nucleotide (Maiden et al. 1998). tbpB alleles that are identical to previously described
sequences (tbpB1, 10, 11, 101) (Linz et al. 2000) were assigned the same numbers and
other alleles were assigned arbitrary numbers from tbpB38 to tbpB66. These allele
assignments were based on an aligned stretch of approximately 660 bp that has been
sequenced from all isolates. (We note that the tbpB1 allele is assigned to both
subgroups III and IV-1 although the complete 2057 bp tbpB sequences from
subgroups III (accession number AJ276909) and IV-1 (AF058689) differ by two
nucleotides outside this aligned region.)
Phylogenetic analyses
tbpB sequences were aligned manually to ensure that codons were not split. The
aligned sequences were analyzed using SPLITSTREE 3.1 (Huson 1998), as described
(Linz et al. 2000). Chi-squared analysis of significance between success and failure
was performed using tests 3 and 4 of CLUMP (Sham & Curtis 1995), which tests the
significance of data in sparse matrices by a Monte Carlo method.
4.4 Results
Genocloud structure of subgroup III
The genetic fine structure of subgroup III was investigated among 502 subgroup
III isolates by using restriction fragment length polymorphism (RFLP) at opaB, opaD,
tbpB, pgm, iga and IS1106A. The isolates tested include 314 subgroup III
meningococci from diverse global sources that have been previously described
(Morelli et al. 1997) plus 188 recent isolates from Mongolia, Moscow, Africa and the
UK. 227 variant alleles were sequenced from representative strains and at least two
alleles were found for each of the six loci.
Table 4.1. Geographic distribution of frequent and rare genotypes of subgroup III.
Frequent genotypes Rare genotypes
Genocloud Pandemic Sources Years Nr. of isolates Nr. of genotypesNr. of isolates
1 1 China 1966 2 3 5
2 1 Moscow 1969-71 14 3 3
3 1,2 Europe, Brazil, China 1969-84 43 23 31
4 2 China 1984-87 26 4 5
5 2 Pilgrims, Africa 1987-98 236 7 8
6 2 Africa 1991-93 27 0
7 2 Africa 1991-93 15 1 1
9 2 The Gambia 1997 8 0
8 3 China, Mongolia, Moscow, Africa, UK1993-2000 66 3 3
Intermediate 4 9
Total 1966-2000 437 48 65
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Each unique combination of alleles is referred to as a genotype and a total of 57
genotypes were found. Most (87%) of the 502 isolates possess one of nine frequent
genotypes (Table 4.1). The nine frequent genotypes differed from each other by one to
six of the six loci (Figure 4.1; see supplemental data for details). The other 48
genotypes were isolated only rarely (one to four isolates). They were isolated
concurrently with a frequent genotype from the same geographical area and differed
from that frequent genotype at only one, or rarely two, of the loci (Figure 4.1;
supplemental data). All three criteria (minimal genetic, physical and temporal
distance) were used to assign rare genotypes to groups consisting of one frequent
genotype plus its close relatives (Figure 4.1). These groups will be referred to as
“genoclouds”.
Six of the genoclouds contain a frequent genotype plus descendent genotypes
but genoclouds 1, 6 and 9 do not fulfill both requirements (Figure 4.1). Genocloud 1
contains only few isolates (Table 4.1). It was designated as a separate genocloud
because it includes all the available subgroup III strains that were isolated from several
million patients with meningococcal disease in China during the mid-1960’s, contains
distinct genotypes and is closely related to the deduced ancestral genotype (see
below). Genoclouds 6 and 9 possess only one frequent genotype and no rare
genotypes. Their designation as genoclouds is somewhat arbitrary and they might
equally well represent the transient expansion of rare genotypes.
Phylogenetic relationships and pandemic spread
By minimizing genetic and temporal distances between the genoclouds, we
constructed a fully parsimonious tree in which each allele arises only once. Four rare
genotypes seem to represent intermediates during the evolution from one gen cloud t
a second and were therefore not assigned to either genocloud (Figure 4.1).
The tree is rooted at genoclouds 1 and 3. These g noclouds share pgm3, iga2,
opaB92 and opaD131 alleles with older strains of the related subgroups IV-1 and IV-2
(Morelli et al. 1997) and the tbpB1 allele with older strains of subgroup IV-1 (Linz et
al. 2000) (Figure 4.1). The other g noclouds possess variant alleles at these loci.
Genoclouds 1 and 3 differ from subgroup IV-1 at the IS1106A locus. Genocloud 1
possesses one IS1106A element inserted into a second, defective IS1106A element
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whereas genocloud 3 possesses only the defective IS1106A element (see supplemental
data). Possibly, genocloud 1 is older and was the direct ancestor of genocloud 3
because an IS1106A element inserted into a second, defective IS1106A element was
also found in subgroup IV-1 (Zhu et al. 1999). Genoclouds 2 and 4 are descended
from genocloud 1 because they possess the same double IS1106A elements and
genoclouds 5-7 and 9 are derived from genocloud 3 because they possess the same
single IS1106A element.
Figure 4.1. Parsimonious relationships among 57 genotypes in nine g noclouds of
subgroup III. Large boxed numbers from 1 to 9 indicate the genocloud designations.
Alleles inherited from common ancestors with other serogroup A subgroups are
shown at the top and subsequent changes are shown next to the arrows that indicate
lines of descent. Numbers in parentheses indicate numbers of isolates of the frequent
genotypes, which are also reflected to a limited extent by the sizes of the circles. Rare
genotypes were parsimoniously grouped in genoclouds after consideration of genetic
relationships, sources and dates of isolation. They are indicated by filled dots whose
sizes indicate the numbers of isolates. The lengths of the lines connecting the dots to
the genocloud circles indicate the numbers of genetic changes from the frequent
genotype. Intermediate strains that were not assigned to genoclouds are shown along
the arrows leading from genocloud 3.
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The first subgroup III pandemic (mid-1960’s to late 1970’s) was associated with
genoclouds 1 to 3 (Table 4.1, Figure 4.1). The second subgroup III pandemic (early
1980’s to present) was associated with genoclouds 3 to 7 and 9. A third pandemic
caused by genocloud 8 seems to have started in China in 1993. The progressive
evolution of genocloud 8 from genocloud 3 is documented by the isolation in China
between 1984 and 1992 of intermediate genotypes with progressive genetic changes.
Genocloud 8 has now been isolated from epidemics in Mongolia (1994-95)
(Anonymous 2001, Zhu et al. 1999), Moscow (1994-97) (Achtman et al. 2001, Zhu et
al. 1999) and Africa (1995-99) (Nicolas et al. 2001, Zhu et al. 1999) and from
endemic disease in the UK (1997-2000).
Mechanisms of genetic change
Alleles that differed by at least 2 bp from parental alleles were considered to
represent import by DNA transformation. This applies to all novel alleles at tbpB (28
alleles) and to one allele each at iga nd pgm (Table 4.2). Similarly, all eight
sequenced IS1106A alleles also resulted from import (supplemental data). Eighteen
alleles at the opaB and opaD loci are mosaic genes resulting from gene
conversion/translocation with segments of orthol gous opa genes (most frequently
opaA and opaJ) that are present elsewhere in the genome (Morelli et al. 1997, Zhu et
al. 1999). Four alleles differed from their parental alleles by only one nucleotide or by
a 12 bp deletion and possibly represent single-step mutations (Table 4.2).
Fitness of individual genetic changes
It is striking that so many novel alleles were observed for the loci investigated
here although only 2 novel alleles were detected for six other housekeeping gene
fragments among 137 subgroup III isolates (Nicola  2001, Achtman et al. 2001).
Possibly sequence polymorphism was particularly high for the loci tested here because
some of them encode gene products that are under selection. Indeed, the tbpB, opaB
and opaD loci encode immunogenic outer membrane proteins, and variants at these
loci might enable the bacteria to escape herd immunity.
Table 4.2. Sources of alleles in 502 subgroup III isolates.
Number of variant alleles
Locus Ancestral
allele
Mutation Import Translocation
iga iga2 1 (iga1) 1 (iga3)
IS1106A Uncertain 8 (IS1106A4-11) ¶
pgm pgm3 1 (pgm11) 1 (pgm19)
opaB opaB92 1 (opaB93)* 2 (opaB94,5202) 11 (5 x opaA; 4 x opaD; 3 x opaJ)*
opaD opaD131 1 (opaD100) 7 (7 x opaJ; 1 x opaB)*
tbpB tbpB1 28 (19 x family 1; 6 x family 4; 3 x family 3)
¶The mechanism by which one additional IS1106A allele (IS1106A99) arose is unclear because that allele is associated with a 12 kb region that
has not been sequenced (see supplemental data).
*The mutation in opaB93 is a 12 bp deletion. Translocations into opaB: from opaA: opaB102, 113, 115, 139, 141; from opaD: opaB100, 114,
131, 1131; from opaJ: opaB116, 140, 142. Translocations into opaD: from opaJ: opaD101, 108, 109, 110, 111, 112, 1101; from opaB: opaD94.
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A conservative test for differences in fitness is to compare the number of descendent
genotypes associated with different classes of genetic change. Changes at the tbpB locus
reflect the import of novel tbpB alleles belonging to one of four very distinct allele families
(Linz et al. 2000). The 28 alleles described here fell into three of the same four families
(Figure 4.2). The ancestral allele was in family 4 and most of the imported alleles were in
family 1. Of the 19 occasions where a tbpB allele in family 1 was imported, only one of these
alleles was inherited by descendent genotypes, a significantly lower rate of dissemination than
for all other observed changes (Table 4.3). These results suggest that the fitness of subgroup
III is impaired by the acquisition of tbpB alleles of family 1. Acquisition of tbpB of family 3
or translocation of alleles from either the opaJor opaA loci to the opaB or opaD loci may also
have resulted in reduced fitness (Table 4.3), but the numbers of such events were too small to
be statistically significant. In contrast, three of the six novel tbpB alleles in family 4, the
ancestral family in subgroup III, disseminated to descendent genotypes.
Figure 4.2. Splits graph (uncorrected Hamming distances) of relationships of ~660 bp
tbpB fragments. Large circled numbers indicate the allele families. The smaller numbers are
tbpB allele numbers. tbpB1 is the ancestral allele in subgroups III and IV-1. tbp10 and tbp11
were previously found in subgroup IV-1 and commensal neisseriae and tbpB101 was found in
N. lactamica (13). tbpB38 through tbpB66 have only been found in subgroup III. Sequences
from reference strains of N. meningitidis for families 1 – 3 (B16B6, 2713, BZ83 and M982)
are italicized.
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Table 4.3. Fitness analysis of genotypic hanges.
No. of genetic events
No. of descendent genotypes: >= 1 (success) 0 (failure)
tbpB family 1 1 18
tbpB family 3 0 3
tbpB family 4 3 3
pgm 1 1
IS1106A 5 4
Translocation of opaJ* 2 8
Translocation of opaA 1 4
Other opa changes* 4 5
iga 1 1
NOTE: p = .01 for the null hypothesis of randomness according to a chi-squared test by
comparing success of tbpBfamily 1 with all other g notypic changes (CLUMP test 3, 100,000
repeats) (21). The null hypothesis was also rejected when changes at opa alleles were
categorized into replacement of opaB (5 successes: 10 failures) or opaD (2:7).
4.5 Discussion
We analyzed microevolution within an epidemiological framework for a globally
representative collection of subgroup III meningococci. Fifty-seven distinct genotypes in nine
genoclouds were detected among 502 strains collected during pandemic spread between 1966
and 2000.
The genocloud concept
We designate a frequent genotype plus its e idemiologically associated descendents as a
genocloud. The nine subgroup III genoclouds contained rare genotypes that differed by one or
occasionally two of the six polymorphic loci. The frequent genotypes in subgroup III differed
from each other by one to six loci (supplemental data). All these bacteria are extremely closely
related because housekeeping gene fragments were highly uniform among representative
isolates (Nicolas et al. 2001, Achtman et al. 2001). Each genocloud persists only transiently
(see below) and subgroup III evolution since 1966 has been marked by the successive
replacement of individual dominant ge oclouds by others.
The genocloud concept may be generally useful for describing sequence variability
among clonally related isolates for many bacterial species. Sequence variation is common in
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most microorganisms and clonally related bacteria from a common epidemiological source
often show some limited genotypic variation (Day et al. 2001). Until now, bacteria have been
subdivided into cl nally related and unrelated groups, with no standard designation for distinct
populations within the clonally related groupings. Furthermore, both genetic variability and
different frequencies of particular genotypes are integral aspects of the genocloud concept
whereas these are lacking in former terminology. Genoclouds are not “quasi-species”, a
mathematical concept that describes an equilibrium population of small genomes (Eigen
1996). Unlike quasi-species, the genetic changes in a genocloud are probably not reversible,
represent unique events that do not happen repeatedly, and are continuously eliminated during
spread from host to host and from country to country.
Immune selection during epidemic spread
In subgroup III, many of the genetic variants are escape variants that can evade the
human immune system (Figure 4.3). Epidemics and pandemics may begin when particularly
fit strains invade a naive human population. Herd immunity develops and selects escape
variants for particularly immunogenic proteins such as TbpB. Most TbpB escape variants
result from the import of DNA from Neisseria lactamica nd Neisseria spp. (Linz et al. 2000)
that encode TbpBs of family 1. Family 1 differs extensively from family 4 (Figure 4.2), which
is ancestral in subgroup III, sufficiently that these two families probably share very few
epitopes. We have shown previously (Linz et al. 2000) that the high rate of import of TbpB
alleles is due to positive selection rather than to an elevated recombination rate: the only
common feature of numerous independent recombination events with different recombination
endpoints was the import of tbpB. Nevertheless, import of TbpB of family 1 (and possibly of
family 3) reduces the long-term fitness of the resulting escape variants. Only one of nineteen
genotypes that had imported family 1 alleles succeeded in generating descendent genotypes
(Table 4.3) whereas half of the imports of a family 4 (ancestral) allele were successful. Thus,
many of the rare genotypes may represent escape variants that have a temporary advantage
due to different antigenic composition even though they are less fit than their parent (Figure
4.3).
The term ‘fitness’, rather than virulence, is appropriate in this context because during
single epidemics, the same erogroup A isolates are isolated from both invasive disease and
healthy carriers (Crowe et al. 1989). Furthermore, there is no evidence for frequent healthy
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carriage of serogroup A meningococci without occasional disease. Thus, for serogroup A, the
existence of descendent genotypes among disease isolates reflects efficient transmission
between individuals and can therefore be used to calculate measures of fitness.
The data are also suggestive of a similar but less strong pattern of selection at the opa
loci. The ancestral subgroup III genotype possessed distinct alleles at all four opa loci (opaA,
opaB, opaD and opaJ). The opa101 allele at the opaJ locus is not normally expressed due to a
stretch of four CTCTT repeats in the signal peptide region which results in a non-functional
translational reading frame. The opa101allele was repeatedly translocated to the opaB and
opaD loci whereas translocation from the other opa loci to opaJ is very rare (Morelli et al.
1997). This asymmetry is suggestive of positive selection for replacement of OpaB or OpaD
by the immunologically distinct Opa101 protein. Transposition of the opa101 allele may also
be detrimental to long-term fitness (Table 4.3), but more observations are needed to test
whether this pattern is statistically significant. It is also likely that genetic variation does not
always reflect selection, either positive or negative. For example, IS1106A sequence variants
are also frequent although it is hard to imagine how different alleles of IS1106A could affect
fitness.
Figure 4.3. A model for the formation of rare genotypes and novel genoclouds. Rare
genotypes arise by a variety of mechanisms, including import of DNA from unrelated
bacteria, translocation of opa alleles and single step mutations. Those variants that affect
antigens and result in immune escape will multiply preferentially due to selection pressures by
the host immune system. However, many of these variants also result in lessened fitness and
are eliminated by competition and bottlenecks during spread from host to host and country to
country. On rare occasions, antigenic variants with increased fitness can form new genoclouds
and repeat the cycle.
Import, Translocation, Mutation
Ï
Frequent genotype
Fitness: ++ + + +++
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Transience of genoclouds
The half-life of nasopharyngeal colonization is only a few months (Blakebrough
et al. 1982) and genoclouds disappear from individual countries and areas after several
years, even in the absence of vaccination (Scholten et al. 1993, Caugant et al. 1994,
Kwara et al. 1998). Genocloud 1 disappeared from China in the 1960’s and epidemic
disease during the 1970’s was caused by subgroup V meningococci (Wang et al.
1992). Genocloud 2 disappeared from Moscow in the 1970’s and was replaced by
subgroups VI and X (Achtman et al. 2001). Genoclouds 1-4 have not been isolated
since 1985. Thus, meningococcal genoclouds only survive if they compete
successfully with their parent and other variant genotypes for transmission to other
countries and geographic areas.
Genoclouds persist by migrating from country to country or by generating new
variants that escape the immune response against previous infections. Our analysis of
the tbpB locus suggests that variants that achieve both significant immune escape and
high fitness are unusual, possibly due to the rarity of appropriate DNA in the available
gene pool. The genocloud structure that we have observed probably reflects how
rarely novel genotypes are generated that combine fitness with immune escape at key
antigenic sites.
The third subgroup III pandemic
A third subgroup III pandemic associated with genocloud 8 began in China in
1993 after a decade of slow, progressive microevolution from genocloud 3. Since
1994, genocloud 8 has caused large epidemics in Mongolia (Anonymous 2001),
Moscow (Achtman et al. 2001) and Africa (Nicolas et al. 2001). Genocloud 8 has now
reached Western Europe and caused several cases of endemic disease in the UK
between 1997 and 2000.
Based on historical experience (Achtman 1990), it might have been expected
that the recent subgroup III epidemics in diverse African countries had surpassed their
zenith. In the past, epidemic waves have not extended much longer than 10 years, and
most African countries in the “meningitis belt” have now experienced major
epidemics caused by genocloud 5 (supplemental data). However, these epidemics do
not seem to have generated long-lasting herd immunity against genocloud 8.
CHAPTER 4. Three meningococcal pandemics56
Genocloud 8 has recently caused epidemics in Sudan, Chad and Niger (supplemental
data), where epidemics had been caused by subgroup III bacteria with pgm3
(presumably genocloud 5) only a few years earlier (Nicolas et al. 2001). These
observations bode poorly for the rapid disappearance of epidemic meningitis from
Africa and raise the possibility of renewed epidemic serogroup A disease in Europe
and the Americas. Prior to epidemics in Norway and Finland in the early 1970’s,
serogroup A disease had long been absent, similarly to the current situation. The
availability of vaccines based on the A polysaccharide can help control epidemics but
new generation A-conjugate vaccines are necessary to ensure the prevention of
epidemic disease on a global basis.
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5.1 Abstract
After the 1996-1998 serogroup A meningococcal meningitis epidemic in the
Kassena-Nankana district of Northern Ghana, a gradual disappearance of the epidemic
strain was observed in a series of five 6-monthly carriage surveys of 37 randomly
selected households. As erogroup A Neisseria meningitidis carriage decreased, that of
X meningococci increased dramatically to reach 18% (53/298) of the people sampled
during the dry season of 2000, coinciding with an outbreak of serogroup X disease.
These carriage patterns were unrelated to that of N. lactamica. Multilocus sequence
typing and pulsed-field gel electrophoresis of the erogroup X bacteria revealed strong
similarity with other strains isolated in Africa during recent decades. Three closely
related clusters with distinct patterns of spread were identified among the Ghanaian
isolates, and further microevolution occurred after they arrived in the district.
Occurrence of serogroup X outbreaks argues for inclusion of this serogroup into a
multivalent conjugate vaccine against N. meningitidis.
5.2 Introduction
Neisseria meningitidis can be classified into at least 13 distinct serogroups based
on the antigenicity of the polysaccharide capsule (Peltola 1983). Serogroups A, B and
C are responsible for over 90% of invasive meningococcal infections worldwide. Most
large meningitis epidemics are caused by serogroup A meningococci. Since World
War II, such epidemics have been rare in industrialised countries but they occur
periodically in the African meningitis belt and in China (Lapeyssonnie 1968, Olyhoek
et al. 1987, Wang et al. 1992, WHO 1998, Caugant 1998). Serogroup C meningococci
also cause disease outbreaks and, occasionally, epidemics (Achtman 1995b,Wang et
al. 1993). Endemic disease is usually caused by m ningococci belonging to ser group
B or C but, occasionally, disease is caused by bacteria belonging to other sero roups
including W135, Y, and X. Serogroup X of Neisseria meningitidis was described in
the 1960’s (Bories et al. 1966, Evans et al. 1968) and a limited number of serogroup X
meningococcal disease cases have been reported from North-America (Ryan and
Hogan 1980), Europe (Grahlow et al. 1986, Pastor et al. 1985), Australia (Hansman
1983), and Africa (Chapter 3, Riou et al. 1996). Some of these have been found to be
associated with complement deficiencies (Fijen et al. 1996, Swart et al. 1993) or AIDS
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(Morla et al. 1992). Recently, two outbreaks of ser group X meningococci have been
observed in Niger (Campagne et al. 1999, Etienne et al. 1990). Serogroup X bacteria
were also found to be very efficient in colonizing a group of military recruits in the
UK (Jones et al. 1998).
In the African meningitis belt, epidemics of serogroup A meningococci occur in
8-12 year cycles, each epidemic wave following a multiyear crescendo-decrescendo
pattern (Moore 1992). Incidence of disease is seasonally dependent, peaking during
the dry season (December-May) and declining rapidly with the onset of the rainy
season (Greenwood et al. 1984). Even during major epidemic waves, case numbers are
low during the rainy season (M ore 1992). The underlying mechanisms leading to the
spread of meningococci and to epidemics of meningococcal disease remain unknown.
Carriage rates of 15% can occur during epidemics in Africa (Blakebrough et al. 1982,
Hassan-King et al. 1988). A population’s susceptibility to epidemic disease might
return as antibody levels decline and herd immunity is diluted by new birth cohorts
and migration (Moore 1992). Variation in virulence between strains of N. meningitidis
and the introduction of a new meningococcal clone into a susceptible population might
also contribute to an epidemic. The extreme environmental conditions present in the
sub-Saharan meningitis belt during the dry season - high temperature, low absolute
humidity and the Harmattan (a dusty wind that blows from the Sahara) - as well as
respiratory co-infections are thought to contribute to an enhanced susceptibility to
meningococcal disease by damaging the local mu osal defences (Moore 1992).
Most individuals infected with meningococci are only colonized. They carry the
bacteria asymptomatically in the nasopharynx and do not develop clinical
meningococcal disease. Therefore, epidemiological analysis of meningococcal
infection in defined populations should include both carrier and case studies.
Meningococci can acquire foreign genes by DNA transformation from unrelated
bacteria including commensal Neisseriae (Linz t al. 2000). Serological cross-
reactions between N. lactamica nd N. meningitidis have also been demonstrated, and
it has been argued that the carriage of N. lactamica may have a role in the
development of natural immunity to meningococcal disease (Cartwright 1995b).
Despite the importance of meningococcal infection as a cause of morbidity and
mortality in countries of the African meningitis belt, few longitudinal carriage studies
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have been undertaken in this region (Blakebrough et al. 1982, Hassan-King et al.
1988).
In the dry season between November 1996 and May 1997, a meningitis epidemic
occurred in Northern Ghana. A total of 18,551 cases with 1,403 deaths were reported
(Tikhomirov et al. 1997). During the 1996-1997 epidemic, 1396 cases and 65 deaths
were registered in the Kassena-Nankana District (Upper East Region) (Enos 1997).
One year later, a smaller meningitis outbreak occurred in the same district with 50
serogroup A subgroup III cases and 10 deaths (Chapter 3). In order to investigate the
dynamics of meningococcal carriage, we conducted a longitudinal carriage study in
the Kassena-Nankana district from 1998-2000, during which time an outbreak of
serogroup X meningococcal meningitis with a high carriage rate was observed.
5.3 Materials and Methods
Study area and population
The study was conducted in the Kass na-Nankana District (KND) of the Upper
East Region of Ghana. The district lies within the guinea Savannah woodland area of
Ghana with a population of 140,000 and has two main seasons; a short wet season
from June to October and a long dry season for the rest of the year. The general
population is rural except for those living in the town of Navro g  (population of
about 20,000). People live in compounds with an average of 10 inhabitants each.
Thirty-seven compounds were randomly selected from a complete listing of the
district population (Navrongo Demographic Surveillance System; (Binka et al. 1996).
The 37 compounds were sampled five times between March 1998 and April 2000,
once in each the dry and rainy season. After obtaining informed consent, a throat swab
was taken from all compound members present at the time of the visit. The swabs
were inoculated directly on Thayer-Martin agar plates which were transported to a
laboratory within two hours. The agar plates were then incubated in candle jars for 24
h at 37oC.
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Characterisation of bacteria
Up to ten random colonies with neisserial morphology were sub-cultured from
each plate. Bacteria that were Gram-negative diplococci, produced cytochrome
oxidase from N,N,N’,N’-tetramethyl-1,4-phenylene-diammoniumdichloride (Merck),
and utilized glucose and maltose but not sucrose in cystine-trypticase agar (Difco),
were analyzed further. Those with beta galactosidase (ONPG discs, Oxoid) were
classified as N. lactamica nd those with gamma-glutamyltransferase activity (MPR 2-
Kit, Boehringer Mannheim) were classified as N. meningitidis. Isolates from these
species were stored in 10% skim milk (Difco) on glass beads at -70oC. The frozen
samples were transported to Switzerland in liquid nitrogen or on dry ice.
Meningococci were serogrouped by slide agglutination with serogroup specific
antisera (Murex) and serotyped/subtyped with monoclonal antibodies by whole cell
ELISA (Wang et al. 1992). They were also screened for diversity by pulsed-field gel
electrophoresis (PFGE) after digestion with NheI and SpeI (Morelli et al. 1997).
Multilocus sequence typing (MLST) was performed (Maid net al. 1998) on a subset
of 20 isolates representing the different PFGE variants of the different serogroups.
Data analysis
The prevalence of carriage and exact binomial confidence intervals were
calculated using STATA statistical software (Stata Corporation 1999). In order to
evaluate age and sex effects on prevalence, we used logistic regression models
including random effects to allow for repeated assessment of the same individuals.
Age and sex effects on incidence were assessed by normal logistic regression.
For serogroup X isolates, distinct NheI and SpeI fragments were assigned
arbitrary numbers. The presence or absence of each fragment was scored in a data
matrix as plus (1) or minus (0). The data matrix was used to construct a neighbour-
joining tree (MEGA version 2b3; (Kumar et al. 2000) based on the number of band
differences between PFGE patterns. For serogroup X strains, a matrix of pairwise
geographic distances between the compound of isolation was compared to the data
matrix of genetic distances by a Mantel-test with 10,000 permutations (GENETIX
version 4.01; Belkhir 2000).
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5.4 Results
The longitudinal carriage rate of N. meningitidis and N. lactamica was
investigated between 1998 and 2000 in the Kassena-Nankana District (KND). Throat
swabs taken on five occasions from 292-308 inhabitants of 37 random compounds
were investigated bacteriologically.
Prevalence and incidence of carriage
The carriage rate of N. lactamica remained constant at around 9% with no
difference between the dry and the wet season. However, the carriage rate of N.
meningitidis of different serogroups changed dramatically. Carriage of serogr up A
meningococci dropped continuously from 3% in April, 1998, to £ 0.3% in April, 2000
(Table 5.1, Figure 5.1). All 14 serogroup A isolates were A:4,21:P1.9 and possessed
PFGE fingerprints similar to those of disease isolates from the meningitis outbreak in
1998 (data not shown). Three representative isolates were MLST sequence type ST5,
as is typical of subgroup III bacteria from Africa (Zhu et l. 2001).
Serogroup X bacteria were first isolated in 1999 (3% of samples) and rose
precipitously to 18% in the dry season of 2000 (Figure 5.1). The estimated incidence
(acquisition rate) was 0.6 per 100 person-months for N. lactamica, 1.0 for serogroup X
meningococci, and 0.2 for meningococci of other serogroups (Table 5.2).
The carriage rate of N. lactamica was highest among children under 5 years of
age and decreased continuously with age (Figure 5.2). In contrast, serogroup X
carriage was highest among 5-14 year olds. Females were more likely to carry and to
acquire N. lactamica (Tables 2 and 3). Males were at higher risk of carrying serogroup
X meningococci than females but there was no such difference in acquisition. Males
were also more likely to carry and to acquire meningoccci of other serogroups.
Table 5.1.   Carriage of N.lactamica nd different serogroups of N.meningitidis during 5 longitudinal carriage surveys conducted in northern Ghana.
MLST type subgroup/
complex
Apr. 1998
(n=300)
Nov. 1998
(n=299)
Apr. 1999
(n=292)
Nov. 1999
(n=308)
Apr. 2000
(n=298)
Total
(n=1497)
DS RS DS RS DS
Change over
timePresence of
n (%) n (%) N (%) n (%) n (%) N (%)
% of
meningococcal
isolates
LRTc12 p
Neisseria lactamica -- -- 28 (9.3) 26 (8.7) 24 (8.2) 30 (9.7) 25 (8.4) 133 (8.9) -- -- ns
Neisseria meningitidis -- -- 14 (4.7) 9 (3.0) 15 (5.1) 13 (4.2) 59 (19.8)110 (7.4) 100
A:4,21:P1.9 ST5 III 9 (3.0)a 4 (1.3)b 2 (0.7) 1 (0.3) 0 (< 0.3)16 (1.1)ab 14.5 15.6 < .001
X:NT:P1.5ST181/ST751 -- 0 (< 0.3) 0 (<0.3) 10 (3.4) 7 (2.3)a 53 (17.8)a 70 (4.7)c 63.6 94.3 < .001
Y:4:P1.5 ST168 -- 4 (1.3) 3 (1.0)a 2 (0.7) 3 (1.0)a 5 (1.7)a 17 (1.1)d 15.5 -- nse
W135:2a:P1.2,5 ST11 ET-37 1 (0.3) 1 (0.3) 0 (< 0.3) 0 (< 0.3) 0 (< 0.3) 2 (0.1) 1.8
PolyAG:NT:NST Nd -- 0 (< 0.3) 1 (0.3) 1 (0.3) 2 (0.6) 1 (0.3) 5 (0.3) 4.5
a polyagglutinable, 1 isolate; b non-groupable, 1 isolate; c polyagglutinable, 2 isolates; d polyagglutinable, 3 isolates; e s rogroups Y, W135 and
PolyAG:NT:NST together; nd: not done; DS: dry season; RS: rainy season; LRT: likelihood ratio test; ns: not significant.
Figure 5.1. Prevalence of carriage of N. lactamica nd different serogroups ofN.
meningitidis during 5 longitudinal carriage surveys conducted in Northern Ghana.
Error bars indicate exact binomial 95% confidence intervals.
Figure 5.2. Age distribution of prevalence of carriage of N. lactamica nd different
serogroups ofN. meningitidis. Error bars indicate exact binomial 95% confidence
intervals.
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Table 5.2. Sex differences in incidence (acquisition) of carriage of N. lactamica nd different serogroups of N.
meningitidis (per 100 person-months).
Acquisition of Total (CI95%) M (CI95%)a F (CI95%)a ORb (CI95%) LRTc12 p
Serogroup X 1.0 (0.7-1.3) 1.2 (0.8-1.7) 0.8 (0.5-1.1) -- -- ns
Other serogroups 0.2 (0.1-0.4) 0.3 (0.1-0.6) 0.1 (0.02-0.3) 3.3 (0.9-12.9) 3.6 0.06
N. lactamica 0.6 (0.4-0.8) 0.3 (0.1-0.6) 0.8 (0.5-1.2) 0.4 (0.2-0.9) 5.8 < .02
a binomial exact, b age adjusted odds ratio, LRT: likelihood ratio test, ns: not significant.
Table 5.3. Sex differences in prevalence of carriage of N. lactamica nd different serogroups of N.meningitidis.
Total (N =1497) M (N = 666) F (N = 831)
Presence of n % (CI95%)a n % (CI95%)a n % (CI95%)a ORb (CI95%) LRTc12 p
Serogroup X 70 4.7 (3.7-5.9) 43 6.4 (4.7-8.6) 27 3.2 (2.2-4.7) 2.0 (1.2–3.3) 7.8 < .01
Other serogroups 40 2.7 (1.9-3.6) 29 4.3 (2.9-6.2) 11 1.3 (0.7-2.4) 3.8 (1.4-10.1) 7.4 < .01
N. lactamica 133 8.9 (7.5-10.4) 47 7.1 (5.2-9.3) 86 10.3 (8.3-12.6) 0.3 (0.1-0.7) 7.4 < .01
a binomial exact, b age adjusted odds ratio, LRT: likelihood ratio test.
CHAPTER 5. Serogroup X N. meningitidis n Ghana66
Only three individuals were colonized simultaneously by N. meningitidis and N.
lactamica. This is fewer than expected assuming independence (Fisher’s exact test: p
< 0.02). However, individuals carrying N. lactamica t any one time were equally
likely to become s rogroup X carriers in subsequent surveys as those who did not
carry N. lactamica. The acquisition of serogroup X bacteria did not differ significantly
between compounds with N. lactamica carriers and compounds without carriers.
People living in compounds with at least one N. lactamica carrier were more
likely to acquire N. lactamica (secondary colonization) than individuals living in
compounds without carriers (OR = 5.0 CI95%: 2.1 - 12.1). As expected for an epidemic
outbreak, most individuals from whom serogroup X bacteria were isolated lived in
compounds where these had not been previously recovered. Nearly 60% of the
compounds sampled became newly infected with serogroup X bacteria at some point
during the study. On average 35% of the inhabitants of a compound (2.5 ± 2.0
individuals; range 1-8) carried s rogroup X meningococci on the first occasion when
these bacteria were detected in that compound.
Cases of meningococcal meningitis
The last confirmed serogroup A meningococcal meningitis case occurred in the
second epidemic year, namely during the dry season of 1998 (Chapter 3). In contrast,
9 cases (56% males) of meningitis were caused by serogroup X meningococci between
March 1998 and April 2000. One of these cases occurred in the dry season of 1998,
during the serogroup A outbreak and was fatal. A second fatal case occurred during
the dry season of 1999. During the dry season of 2000 seven cases were identified, all
of whom survived. The median age of the 9 cases was 6 years (mean = 9.7, range: 1 -
32). Serogroup X disease was not associated with complement or properdin deficiency
in any of the four sera tested (Kirschfink 1997). The ratio of cases of serogroup A
disease per carrier in 1998 was 40 fold higher than that for serogroup X meningococci
in 2000.
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Population structure and spread of serogroup X meningococci
Serogroup X meningococci isolated in Africa between 1970 and 2000 can be
assigned to two groups, a and b, by PFGE. Most serogroup X isolates from Chad, Mali
and Niger were group a, strains from Burkina Faso were group b (Chapter 6). These
PFGE patterns differ in 8 NheI and 3 SpeI fragments. Seventy-eight of the 79
serogroup X isolates from Ghana belonged to group b and one (Figure 5.3, track 14) to
group a. The group a isolate was MLST type ST181, while 12 representative group b
isolates were ST751 which differs at two of the seven MLST loci. The group b isolates
from Ghana were not totally uniform by PFGE. They shared 11 uniform NheIbands
(Figure 5.3) but 8 other bands were polymorphic. Four smaller fragments could not be
evaluated due to lack of resolution. Similarly, the group b isolates contained 19
uniform SpeI fragments, 6 that were polymorphic and 3 that could not be evaluated.
The combined data from both restriction digests resulted in nine PFGE subtypes
within the group b Ghanaian isolates (Figure 5.3).
Phylogenetic analysis of the PFGE data revealed that eight of the nine subtypes
from group b belonged to three clusters (1, 2 and 3) and that one subtype represented
by the sole isolate from 1998 was very different. Both neighbor-joining (Figure 5.4)
and maximal parsimony algorithms (data not shown) yielded comparable results. For
the cluster 1, 2 and 3 isolates, there was a significant correlation between the pairwise
genetic distances and the geographic distances between the compounds of isolation
(Pearson r = 0.34, Mantel-test, p < .0001). The correlation was even stronger between
geographic distances and cluster assignment (Pearson r = 0.43, Mantel-test, p < .0001).
All three clusters were isolated from both carriers and meningitis patients (cluster 1: 4
patients; 2: 1; 3: 3). There was no significant difference in the case to healthy carrier
ratio between the tree clusters. All three clusters were found in 1999. Furthermore,
cluster 1 and 3 were also isolated in Burkina Faso between 1996 and 1998 (Figure
5.4). These results suggest that the three clusters evolved outside Ghana and were
imported concomitantly in 1999.
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Figure 5.3. PFGE patterns of NheI and SpeI digested chromosomal DNA of
representative serogroup X meningococci from Northern Ghana. Strains were loaded
in tracks 1-19 in the following order (track: strain): 1:Z9389; 2: Z9396; 3: Z9381; 4:
Z9292; 5: Z9295; 6: Z9399; 7: Z9401; 8: Z8329; 9: Z8331; 10: Z9301; 11: Z9300; 12:
Z9297; 13: Z9383; 14: Z9413; 15: Z9294; 16: Z7091; 17: Z8336; 18: Z9392; 19:
Z9293. Molecular weight markers were loaded in the flanking tracks as indicated
(LM: low range marker; MM: midrange marker); their molecular weights are
indicated at the left.
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Figure 5.4. Neighbor-joining tree based on the PFGE subtypes of serogroup X
meningococci isolated in Northern Ghana. The distance used was the number of band
differences. Numbers at nodes are the percentages of 1000 bootstrap replicates in
which these nodes appeared. Only nodes with percentages >50% were included.
Strains labeled with ‘D’ or ‘R’ have been isolated during the dry or the rainy season,
respectively.
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The 3 clusters showed different patterns of spread. Cluster 1 bacteria colonized
only one compound in 1999 and spread extensively through the central part of the
district in 2000 (Figure 5.5). Cluster 2 colonized a few compounds in the East of the
district in 1999 and spread to only 3 other compounds thereafter. Cluster 3 spread
from East to West and continued to diversify (Figure 5.4). Cluster 3 isolates from 1999
and Burkina Faso (1998) were located in branches nearer the root of the tree and seem
to be ancestral. Most cluster 3 isolates from 2000 were in descendent twigs, indicating
recent descent.
5.5 Discussion
Meningococcal carriage rates of up to 30% can be observed during serogro p A
epidemics in Africa (Moore 1992), but lower carriage rates have been observed in
some epidemics (Hassan-King et al. 1979), and carriage is generally infrequent during
inter-epidemic periods (Achtman 1995b, Blakebrough et al. 1982, Hassan-King et al.
1988). A major serogroup A epidemic occurred in northern Ghana in 1996-98
(Chapter 3). The data presented here show that in 1998, the carriage prevalence of the
epidemic strain was only 3%. During the following 2 years, serogroup A carriage
decreased even further and no serogroup A carrier was identified in 2000. These
results resemble those for a serogroup A subgroup IV-1 epidemic in The Gambia in
the 1980’s (Hassan-King et al. 1988).
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Figure 5.5. Spatial distribution of compounds with carriers of serogr up X N.
meningitidis and N. lactamica at different time points. Black dots indicate the
compounds that were sampled. The red, yellow and green dots indicate the compound
where serogroup X N. meningitidis carriers were identified. The three colors
correspond to the three clusters identified in the phylogenetic analysis (Figure 5.4).
Compounds of meningitis cases which could be identified are indicated by colored
triangles. Compounds with N. lactamica carriers are indicated by gray circles.
There was an initial increase in carriage of serogr up X during the dry season of
1999, followed by a second strong increase during the dry season of 2000. Season has
no effect on meningococcal carriage, both in temperate zones and in Africa (De Wals
et al. 1983, Gold et al. 1978a, Greenwood et al. 1984) and is therefore unlikely to
account for the observed increase in serogroup X carriage. In contrast, similar
temporal patterns are typical of serogroup A epidemics in the African Meningitis Belt
where large epidemics are often preceded by localized outbreaks one year earlier
(Moore 1992). Prevalence of serogroup X carriage was highest in 10-14 year olds,
similar to the age patterns observed during large serogroup A epidemics where older
children have the highest risk of disease (Gr enwood et al. 1987). Although there were
sex differences in carriage prevalence and incidence in N. lactam ca nd meningococci
of other serogroups, there was no such difference in acquisition of serogroup X
bacteria, reflecting the epidemic nature of the colonization process, i.e. the whole
population being at risk. Furthermore, serogroup X meningococci were mostly
acquired through primary colonization, emphasizing that a new bacterial wave was
entering the area.
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Our findings are consistent with the hypothesis that in the African meningitis
belt, meningococci of different s rogroups invade specific populations in successive
waves. Low carriage rates during inter-epidemic periods alternate with periods of high
carriage which can result in epidemics of disease if the bacteria are particularly
virulent. However, frequent carriage of bacteria of low virulence would normally not
be documented because of the low burden of disease. The different cas  to carriage
ratios for serogroup A and X meningococci possibly reflect such differences in
virulence. However, it has been postulated that epidemic disease reflects a lack of herd
immunity (Moore 1992), and it remains possible that carriage of serogr up A bacteria
between 1996 to 1998 stimulated protective immunity against subsequent disease by
serogroup X meningococci. Secondary factors like respiratory tract co-infections may
also be necessary for epidemics to o cur (Achtman 1995b) and might have been
lacking during the epidemic of colonization by serogroup X meningococci.
Meningococcal disease (as opposed to carriage) is highly seasonal in the African
Meningitis Belt (Greenwood et al. 1984). In agreement, all 9 cases of meningococcal
meningitis in our study occurred exclusively during the dry season.
It has been suggested that exposure to N. lactamica may stimulate natural
immunity to meningococcal disease (Cartwright 1995b, Gold et al. 1978a). A negative
correlation between carriage of N. lactamica nd either carriage of N. meningitidis or
meningococcal disease has been found in the Faroe islands (Olsen et al 1991). In one
African study involving N. lactamica, there was no association between carriage of N.
meningitidis and N. lactamica (Blakebrough et al. 1982). We found a negative
association between the carriage of both species in this study. However, carriage of N.
lactamica did not correlate with the acquisition of serogroup X meningococci or its
absence, either at the individual or the compound level. Thus it appears that in the
African Meningitis Belt, carriage of N. lactamica does not reduce colonization of the
nasopharynx with meningococci. The age and sex patterns of prevalence and
acquisition of N. lactamica differed from those of N. meningitidis. N. lactamica was
carried predominantly by infants and young children, similarly to data from Europe
and other African studies (Blakebrough et al. 1982, Cartwright et al. 1987, Gold et al.
1978a, Olsen et al. 1991). N. lactamica was mainly acquired in compounds where
carriers were already present, indicating that it is transmitted from person to person
within compounds, and that re-colonization is probably frequent.
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The serogroup X meningococci that colonized the population of the Kassana-
Nankana district have been isolated in West Africa for at least three decades (Chapter
6). Bacteria belonging to the same clonal grouping caused a meningitis outbreak with
more than 60 cases in Niger in 1997 (Chapter 6, Campagne t al. 1999). Some
microheterogeneity was found among the Ghanaian serogroup X isolates. The
different PFGE types identified clustered in three phylogenetic clusters. The three
clusters did not differ in virulence but exhibited very distinct patterns of dispersal.
Cluster 1 spread extensively, without genetic diversification. Cluster 2 which was
more diverse than cluster 1 colonized only a few compounds and did not spread
further. Cluster 3 spread and diversified during the process.
Although serogroup A, B and C are responsible for over 90% of mening coccal
disease worldwide, recent outbreaks of serogroup X and W-135 meningococci
illustrate that these serogroups also have considerable pathogenic potential (Campagne
et al. 1999, Etienne et al. 1990, Taha et al. 2000). In Streptococcus pneumoniae, the
introduction of polyvalent capsule polysaccharide conjugate vaccines seems to have
induced changes in bacterial population structure of carrier isolates (Mbelle et al.
1999, Obaro et al. 1996). The effects of widespread immunization with conjugate
polysaccharide vaccines on the population structure of meningococci is also under
discussion (Maiden & Spratt 1999). Selection can lead to frequent isolation of escape
variants (Chapter 4, Linz et al. 2000). Repeated vaccination against serogroup A and C
carried out in many African countries has the potential to select meningoco ci of other
serogroups, such as serogroup X and might result in a changed profile of
meningococcal disease. It is therefore very important that comprehensive conjugate
vaccines, including X polysaccharide, be developed as soon as possible.
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6.1 Abstract
The genetic diversity of 134 serogroup X Neisseria meningitis d ease and
carrier isolates from different countries in Africa, Europe and North America was
analyzed by multilocus sequence typing and pulsed-field gel electrophoresis. Most of
the European and American isolates were highly diverse. However, one clonal
grouping was identified among sporadic disease and carrier strains isolated over the
last two decades in the UK, The Netherlands, Germany and the U.S.A. In contrast to
the diversity among the European and American isolates, most carrier and disease
isolates recovered in different countries of the African Meningitis Belt over the last
thirty years were members of a second clonal grouping. During the last decade these
bacteria have caused meningitis outbreaks in Niger and in Ghana. These results argue
for the development of a comprehensive conjugate vaccine including serogro p X
polysaccharide.
6.2 Introduction
Bacterial meningitis due to Neisseria meningitidis (the meningococcus) remains
an important global public health problem. Epidemics in Africa are usually caused by
serogroup A meningococci while sporadic cases, outbreaks, and hyperendemic disease
in Europe and the United States are usually caused by serogroups B and C (Achtman
1995b). Occasionally however, endemic disease and outbreaks are caused by bacteria
belonging to other s ogroups including W135, Y, and X. Serogroup X Neisseria
meningitidis was described in the 1960’s (Bories et al. 1966, Evans et al. 1968) and
serogroup X meningitis has been observed on a few occasions in North America
(Ryan & Hogan 1980), Europe (Grahlow et al. 1986, Pastor et al. 1985), Australia
(Hansman 1983) and Africa  (Chapter 3, Riou et al 1996) and outbreaks have been
reported in Niger (Campagne t a. 1999, Etienne et al. 1990) and in Ghana (Chapter
5). In some cases, serogroup X disease was associated with a deficiency of particular
complement components (Fijen et al. 1996, Swart e al. 1993) or with AIDS (Morla et
al. 1992).
Asymptomatic nasopharyngeal carriage of N. meningitidis  common and only
occasionally do the bacteria invade the blood stream and cerebrospinal fluid to cause
disease. Meningococcal populations are highly diverse and it is thought that linea es
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of meningococci with an elevated capacity to cause invasive disease arise periodically
and spread, sometimes globally (Maiden et al. 1998). Relatively few of these
hyperinvasive lineages or clonal groupings are responsible for most of the burden of
meningococcal disease worldwide (Caugant 1998). These clonal groupings diversify
during spread (Chapter 4, Caugant et al. 1986) , primarily due to frequent horizontal
genetic exchange (Chapter 4, Kriz et al. 1999, Linz et al. 2000). Many variants are
isolated only rarely and from a single country due to the bottlenecks associated with
geographic spread and to loss of fitness (Chapter 4, Morelli et al. 1997). The
population structure of N. meningitidis  panmictic (Maynard Smith et al. 1993) but
that of some groupings such as epidemic serogroup A meningococci is largely clonal
(Achtman et al. 2001). The population structure of s r group X meningococci has not
yet been investigated in detail.
After an epidemic of serogroup A disease in 1997-98 in Northern Ghana
(Chapter 3), a longitudinal carriage study was performed in order to investigate the
dynamics of meningococcal carriage during an inter-epidemic period (Chapter 5).
Surprisingly, a sharp increase in the healthy nasop aryngeal carriage of s r group X
meningococci was observed, accompanied by several cases of serogroup X meningitis.
In order to investigate the phylogenetic relationships of these bacteria, we compared
the isolates from Ghana with other serog oup X meningococci isolated during recent
decades in Africa, Europe and North America.
6.3 Materials and Methods
Bacterial strains
134 N. meningitidis olates of serogroup X were analyzed by pulsed-field gel
electrophoresis (130 isolates) or MLST (41). Of these bacteria, 102 were isolated in
Africa between 1970 and 2000: from meningitis patients (9 isolates) and healthy
carriers (70) in Ghana, 1998-2000; from healthy carriers in Mali in 1970 (9) and 1990-
91 (4); and from diseased patients in Chad (1995, 1), Niger (1997-98, 4) and Burkina
Faso (1996-98, 5). Six of these isolates were not tested serologically. The other 96
were NT: P1.5.
32 serogroup X strains were isolated between 1988 and 2000 in the UK (22
isolates), Germany (3), U.S.A. (4), France (1), Norway (1) and the Netherlands (1).
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The 26 strains tested possessed diverse serotypes (2b, 4, 4/21, 14, 16, 21, 22) and
serosubtypes (NST, P1.5, P1.5,10, P1. 7, P1.12, P1.14, P1.15, P1.16) in various
combinations.
Molecular typing of bacteria
Pulsed-field gel electrophoresis (PFGE) was performed by digesting
chromosomal DNA prepared in agarose blocks with N eI and SpeI as described
(Morelli et al. 1997). MLST was performed by sequencing gene fragments of abcZ,
adk, aroE, fumC, gdh, pdhC and pgm as described (Maiden t al. 1998;
http://www/mlst.net). The detailed MLST results and sources of isolates have been
deposited in a public database (http://www.mlst.net). Additional MLST data for 31
isolates in 30 sequence types was obtained from http://www.mlst.net
Data analysis
A neighbour joining (NJ) tree was constructed using the numbers of MLST
allele differences with Bionumerics 2.0 (Kortrijk 2000).
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6.4 Results
Pulsed-field gel electrophoresis (PFGE) with two discriminatory rare-cutting
enzymes was used to identify groups of closely related strains among 130 isolates of
serogroup X N. meningitidis from different countries in Africa, Europe and North
America. The results showed that all but three of 102 isolates from Africa yielded very
similar PFGE patterns (Figure 6.1, clonal grouping X-I). In contrast, 19 of 32 isolates
from Europe and North America yielded distinct PFGE patterns (Figure 6.2) that
differed from those of the African isolates. However, very similar PFGE patterns were
observed for 13 isolates from the U.K., Germany, the Netherlands and the U.S.A.
(Figure 6.2, clonal grouping X-II).
Figure 6.1. Two groups of PFGE patterns among NheI and SpeI digested
chromosomal DNA from selected serogroup X N. meningitidis trains isolated in
Africa. Track: strain: 1: D93 (ST188); 2: 1970; 3: 3187; 4: 3529; 5: D5; 6:
LNP13407; 7: LNP14964; 8: LNP15040; 9: 97013; 10: 97014; 11: Z9413; 12:
LNP14297; 13: LNP15061; 14: BF2/97; 15: BF5/97; 16: BF1/98; 17: Z7091; 18:
Z8336; 19: Z9291. Molecular weight markers were loaded in the flanking tracks as
indicated (L: low range marker; M: midrange marker); thei  molecular weights are
indicated at the left. Characteristic band differences are indicated on the right.
Figure 6.2. PFGE patterns of NheI digested chromosomal DNA of selected
serogroup X N. meningitids i olates from Europe and the USA plus a prototype isolate
from Ghana (track 13). Track: strain: 1: E26; 2: X4571; 3: X4890; 4: M2526; 5:
M4222; 6: M3772; 7: LNP17351; 8: J88-603; 9: K89-1395; 10: L92-1413; 11: M98-
253172; 12: M00-240465; 13: Z9291; 14: M98-252848; 15: M98-252718; 16: M99-
240899; 17: X5967; 18: 860060; 19: M4370.
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A total of 41 isolates representing each distinct PFGE pattern was analyzed by
MLST. For those, bacteria where multiple isolates with a similar PFGE pattern had
been detected, we tested at least one representative from each year and country of
isolation. Together with other data included in the MLST WEB site
(http://www.mlst.net), 39 distinct sequence types (STs) have been found among 50
serogroup X meningococci. The general structure of a NJ tree of allelic differences is
that of a bush with little phylogenetic structure (Figure 6.3). However, isolates with
similar PFGE patterns were assigned to closely related STs. All 29 clonal grouping X-
I isolates analyzed by MLST were in STs ST181, ST182 or ST751 (Figure 6.3), which
differ from each other by one to three of the seven g ne fragments (Table 6.1).
Similarly; all five clonal grouping X-II isolates were in STs 24 and 750, which differ
by one of the seven gene fragments (Table 6.1). The 3 exceptional African isolates
(Mali, 1991) were in ST188 which is very distinct from STs of clonal grouping X-I
(Figure 6.3). These results show that numerous serogroup X isolates from Africa and
nearly half of the serogroup X isolates from Europe and North America belong to two
clonal groupings while other serogroup X isolates from Europe or North America are
quite diverse.
Serological results
African isolates of clonal grouping X-I were NT:P1.5. The 11 North American
and European isolates of cl nal grouping X-II for which serological data were
available were 21:P1.16 whereas diverse serotype and serosubtype patterns were found
for the other isolates from North America and Europe (see p.82).
Figure 3. Neighbor-joining phenogram of allelic identities among 39 MLST sequence
types from serogroup X N. meningitidis. Numbers at nodes are the percentages of
1000 bootstrap replicates in which these nodes appeared. Only nodes with percentages
>50% were included. The two boxes indicate clonal groupings that were detected by
MLST and/or PFGE.
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Table 6.1. MLST results of two serogroup X N. meningitidis clonal groupings.
Allele numbers
ST abcZ adk aroE fumC gdh pdhC pgm Country
(no. of isolates)
Year
24 2 5 2 7 15 20 5 Netherlands (1) /
USA (1)
1986, 1993
750 2 5 2 9 15 20 5 UK (2) / Germany (1)998-1999
181 10 3 15 7 5 41 31 Mali (6) / Chad (1) /
Niger (2) / Ghana (1)
1970-2000
182 10 3 15 26 5 41 31 Mali (4) 1970
751 10 3 15 7 8 41 6 Burkina Faso (3) /
Ghana (12)
1996-2000
Finer groups within clonal grouping X-I
The PFGE patterns distinguished two finer groups (Ia and Ib) within clonal
grouping X-I that differ consistently in eight NheI and three SpeI fragments (Figure
6.1). All 14 group Ia strains that were tested were either ST181 or ST182, which differ
at one of the seven g e fragments (Table 6.1). All 15 group Ib strains tested were
ST751, which differs from ST181 and ST182 at two to three loci (Table 6.1). Group Ia
included 10 isolates from Mali (1970/1990), 4 isolates from Niger (1997-98), the sole
isolate from Chad (1995), as well as one of 79 isolates from Ghana (2000). All five
isolates from Burkina Faso (1996-98) and 78/79 isolates from Ghana (1998-2000)
were in group Ib.
6.5 Discussion
The general population structure of N. meningitidis i  panmictic due to the
frequent import of alleles from unrelated N iss riae (Maynard Smith et al. 1993, Linz
et al. 2000). Phylogenetic trees of different housekeeping genes from N. meningitidis
are no more congruent with each other than with random trees (Feil et al. 2001). The
results for sequence typing of housekeeping genes of serogroup X meningococci that
are presented here also fit this pattern. Phylogenetic analysis of allele differences
resulted in a bush-like tree that does not seem to contain any deep phylogenetic
information. It was therefore surprising to find two clonal groupings within this
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otherwise panmictic group of bacteria. The same isolates were assigned to both clo al
groupings by two independent methods, MLST and PFGE, indicating that these
assignments reflect real genetic relationships and are not dependent on the
methodology used. Similar concordant genetic relationships were also discerned
among epidemic serogroup A N. meningitidis by multilocus enzyme electrophoresis
(MLEE), random amplification of polymorphic DNA (RAPD) and MLST; population
genetic analyses confirmed that the population structure of these bacteria is clonal
(Bart et al. 2001). Concordant groupings were also discerned by MLEE and MLST
among the so-called “hyper-virulent” serogroup B and C isolates of the ET-5 complex,
ET-37 complex, lineage III and cluster A4 (Maiden et al. 1998). Although it has been
suggested that their apparent clonality may reflect an epidemic population structure
(Maynard Smith et al. 1993), this possibility has been excluded for epidemic
serogroup A meningococci (Bart et al. 2001) and therefore it now appears that
multiple clonal groupings exist within N. meningitidis even though the population
structure of most of the species is panmictic.
The population structure of subgroup III serogroup A meningococci seems to
represent continual replacement of fit genotypes by each other during periods of
several years to decades (Chapter 4). In subgroup III, nine genoclouds, each consisting
of a frequent genotype plus its rarer less fit variants, have been identified during three
decades of pandemic spread. The PFGE data presented here for clonal grouping I of
serogroup X suggest that clonal grouping X-I also possesses a genocloud structure.
Two sets of PFGE variants (group Ia and Ib), which might each represent a g ocloud,
were detected in different countries (Mali, Chad and Niger versus Burkina Faso and
Ghana). Additional analyses of polymorphic genes would be necessary to clarify the
uniformity of these groups and to test whether how similar their population structure is
to that of subgroup III.
Both serogroup X clonal groupings described here were isolated over decades,
on multiple occasions and from diverse locations. Clonal grouping X-I (1970-2000)
was isolated from different countries in West Africa and clon l grouping X-II (1986-
99) was isolated from Europe and North America. For clonal grouping X-I in Ghana,
the disease rate per healthy carriers was estimated to be 3/10,000 (Chapter 5). Clonal
grouping X-1 is thus of considerably lower virulence than serogroup B ET-5 complex
bacteria (disease/carrier rate of 2,100/10,000; The Stonehouse survey: Cartwright et al.
CHAPTER 6. Clonal groupings in serogroup X90
1987)) or serogroup A subgroup III bacteria during a post-epidemic period in a
vaccinated population (100/10,000; Chapter 5). The relationship between bacterial
fitness and clonality has not yet been investigated extensively among natural isolates.
Variation between bacterial genotypes in virulence, for example in Streptococcus
pneumoniae (Smith et al. 1993) and Staphylococcus aureus (Day et al. 2001), leads to
more uniformity in disease isolates than in carriage organism. However, the data
presented here suggest that the clonal structure of certain me ingococcal genotypes
need not reflect virulence but rather is associated with genotypes that are particularly
fit at colonizing the nasopharynx and spreading from one person to the next.
Although clonal grouping X-I bacteria are less virulent than serogroup A and B
meningococci, they are pathogenic. Most of the strains described here were isolated
from asymptomatic carriers or from rare endemic cases. However, group Ia caused a
meningitis outbreak with more that 60 cases in 1997 in Niger (Campagn  t al. 1999).
Group Ib caused a smaller outbreak in 2000 in Ghana (Chapter 5). These results
suggest that X-I meningococci may be capable of causing epidemics. Meningococci
are naturally transformable and horizontal DNA transfer is frequent in these bacteria
(Kriz et al. 1999, Linz et al. 2000, Morelli et al. 1997). Meningococcal carriage is
usually low in inter-epidemic periods in Africa (Chapter 5, Achtman 1995b,
Blakebrough et al. 1982, Hassan-King et al. 1988). This offers less opportunity for
horizontal genetic exchange and could account for the low genetic variability among
serogroup X meningococci in Africa.
For over a decade, many countries within the African meningitis belt have
vaccinated extensively with A/C polysaccharide vaccines (Tikhomirov et al. 1997).
Recently, mass vaccination with conjugated serogroup C vaccines has been
implemented in the UK with strong initial protection (Ramsay et al. 2001). However,
if effective, these vaccines may well select for the spread of bacteria against which
they do not protect (Maiden & Spratt 1999), including unusual causes of disease such
as serogroups Y, W135 and X. Capsule switching due to DNA transformation has
been documented (Swartley et al. 1997, Vogel t al. 2000) and it is conceivable that
effective vaccination against serogroups A and C may select for capsule switch
variants of fit genotypes that express a capsular polysaccharide that is not included in
the vaccination program. The recent outbreaks after the Hajj pilgrimage of 2000 that
were caused by W135 ET-37 complex eningococci (Taha et al. 2000, Popovic et al.
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2000) may reflect exactly such selection. These findings support the development of
comprehensive conjugate v ccines which include capsular polysaccharides from
formerly rare causes of disease such as serogroup X.
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7.1 Abstract
Up to 50% of meningococci carried in industrialized countries are non-
serogroupable, but this proportion is much lower in Africa. Carriage of non-
serogroupable meningococci may protect against meningococcal disease by eliciting
cross-reactive immunity against pathogenic strains. Susceptibility to epidemics may
thus be increased by low levels of carriage in Africa.
7.2 Introduction
Meningococcal disease remains a major public health concern, especially in the
African Meningitis Belt where large meningitis epidemics recur every 8-12 years
(Achtman 1995b). Asymptomatic nasopharyngeal carriage of Neisseria meningitidis
is common in Europe and North America. The overall carriage rate is about 10%, with
peak carriage rates of up to 25% in late teenage and early adult life (Cartwright
1995b). Many strains isolated from the nasopharynx of healthy carriers express little
or no capsular polysaccharide and consequently cannot be assigned to a specific
serogroup. Surveys in Europe and the USA found that between 40% and 50% of
meningococci from healthy carriers are serologically non-groupable (NG)
(Ala'Aldeen et al. 2000, Andersen t al. 1998, Cartwright et al. 1987, Caugant et al.
1994, Gold et al. 1978b). Encapsulation is thought to reduce adherence to
oropharyngeal epithelial cells and loss of expression of capsular polysaccharide may
be an adaptation to long-term pharyngeal carriage (Cartwri ht 1995b).  Invasion of
immunocompetent hosts is dependent on the expression of capsular polysaccharide
and meningococcal strains which express no capsular polysaccharide have very
limited pathogenic potential. Colonization with NG strains may, however, be
beneficial for the host by eliciting potentially cross-reactive immune responses to non-
capsular meningococcal surface antigens (Cartwright 1995b). It has also been
suggested that exposure to N. lactamica may stimulate natural immunity to
meningococcal disease (Cartwright 1995b, Gold et al. 1978a). However, the few
longitudinal carriage studies carried out in Africa showed that the carriage of N.
lactamica had no influence on the dynamics of eningococcal carriage (Chapter 5,
Blakebrough et al. 1982).
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We recently carried out a three-year longitudinal carriage study of N.
meningitidis n the Kassana-Nankana district of Northern Ghana (Chapter 5). During
five 6-monthly surveys of 300 randomly selected people, 110 meningococcal isolates
were recovered. A, X and Y were the dominant serogroups, and no other serogroups
were found except for two serogroup W135 isolates. During the course of our studies,
there were two outbreaks of meningitis, one caused by serogroup A (subgroup III) and
the other by serogroup X (Chapter 5).
7.3 Results and Discussion
Twelve of the 110 carrier isolates (11%) were NG. A similarly low proportion
of NG strains was found during studies in Nigeria (Blak brough et al. 1982) and Mali
(M.A., unpublished). Seven of the 12 NG carrier isolates from Ghana had the same
serotype and serosubtype as serogroup A, X or Y carrier strains isolated from the
same person or in the same household. Analysis by mult locus sequence typing
(Maiden et al. 1998) and pulsed-field gel electrophoresis (PFGE; (Morelli et al.
1997)) of five of these NG isolates showed that they had the same sequence type (ST)
and identical PFGE fingerprints as strains of the corresponding s rogroup (Figure
7.1). These observations suggest that the NG isolates represent capsule-deficient
phase variants as shown for ser group B meningococci (Hammerschmidt et al. 1996)
and that the genetic diversity of non-encapsulated meningococci in Africa is low.
Our data indicate that in contrast to Europe and the USA, carriage of non-
encapsulated meningococci and other non-pathogenic meni gococci is infrequent in
Africa, and cannot contribute markedly to protection through cross-immunity.
Similarly, cross-immunity does not seem to be stimulated by carriage of N. lactamica
(Gagneux, submitted). Thus, the general population is less protected by cross-
immunity than in Europe or the USA. This may be an important factor for the
magnitude of epidemic disease when pathogenic meningo occi are imported.
We thank all the subjects who participated in the study and acknowledge the
support by Alex Nazzar. This work was funded by the Stanley Thomas Johnson
Foundation.
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Figure 7.1. PFGE patterns of NheI and SpeI digested chromosomal DNA of three
selected pairs of serogroupable/non-groupable (NG) N. meningitis trains from
Northern Ghana. Strains were loaded in tracks 1-6 in the following order (track:
strain: ): 1: Z9567; 2: Z8349; 3: Z9300; 4: Z9301; 5: Z8338; 6: Z8347. The serogroup
is indicated on the top. The serotype/subtypes and MLST sequence types (ST) were:
tracks 1/2: 4,21:P1.9 and ST5; tracks 3/4: NT:P1.5 and ST751; tracks 5/6: 4:P1.5 and
ST168. Strains on tracks 3/4 are sequential isolates from the same individual isolated
6 months apart. Strains on tracks 1/2 and 5/6 were isolated from different individuals
in same households, respectively.
SpeINheI
 A     NG X    NG Y     NG A     NG  X    NG  Y     NG
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CHAPTER 8. Discussion & Conclusions 97
GENERAL DISCUSSION AND CONCLUSIONS
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Detailed discussions of the results of the individual studies are found in each of
the respective chapters. This section will start with an assessment of the power of the
experimental methodologies used and will be followed by a discussion of the main
findings, their implications and suggestions for future research.
8.1 Methodology
The main goal of the work presented in this thesis was to contribute to the
understanding of the epidemiology of meningococcal meningitis in the African
meningitis belt and to elucidate possible mechanisms responsible for the occurrence
of epidemics in this area. Our approach included hospital-based case studies and field-
based longitudinal cross-sectional carriage surveys. The studies focused on the
epidemiological characteristics of the meningitis patients, on the dynamics of
nasopharyngeal carriage, and on the population structure and micro-evolution of the
recovered disease and carriage isolates by comparing them to meningococci isolated
in other parts of the world. We used conventional epidemiological tools to study the
patient and carrier characteristics, and a variety of molecular typing and phylogenetic
analysis techniques to investigate the microbiological aspects.
Study population, design and field methodology
All suspected meningitis patients presenting at the War Memorial Hospital in
Navrongo or at one of the three Health Centers in the Kassena-Nankana District were
recruited (Chapter 3). During the time of the serogroup A outbreak in 1998, the three
medical assistants in charge of the Health Centers were specially trained in doing
lumbar punctures, since referral would have significantly delayed the diagnosis and
the start of treatment. Motorbikes were used to transport the cerebrospinal fluid
specimens to the field laboratory.
The compounds included in the longitudinal carriage surveys were randomly
selected from a complete listing of all the compounds in the district (Chapter 5). All
these compounds and their inhabitants are included in the Navrongo Demographic
Surveillance System (Binka et al. 1996). Our sample was therefore representative of
the whole population of the Kassena-Nankana district.
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The intervals between surveys were approximately 6 months. Based on the
clearing probabilities calculated from our longitudinal data, we estimated a mean
duration of carriage of 9.1 months (CI95%: 7.6-12.1) for N. meningitidis. A similar
duration of carriage has been found by Greenfield et al. (1971), but other studies have
estimated a duration of 3-5 months only (Blakebrough et al. 1982, Gold et al. 1978a).
Our estimate of the duration of carriage of N. lactamica was 18.0 months (CI95%:
13.4-25.8), which is considerably longer than the estimates from other studies where a
duration of 4 months has been estimated (Blakebrough et al. 1982, Gold et al. 1978a).
The optimal design for estimating the duration of carriage depends on the degree of
heterogeneity in duration. It is likely that some of the differences in estimates result
from different methodologies used.
However, the main objectives of our studies were to investigate the dynamics of
carriage in relation to season and the succession of waves of colonization over a
period of several years, ideally covering a whole period between two epidemics. In
fact, the six-monthly carriage surveys are currently ongoing and two additional
sampling campaigns have already been carried out (November 2000 and April 2001).
Field laboratory and technology transfer
The establishment of a field laboratory at the N vrongo Health Research
Center/War Memorial Hospital allowed us to cultivate and characterize the isolate to
the species and serogroup level in Ghana, and to transfer the cryopreserved bacteria to
Switzerland for more detailed analyses. Two Ghanaian laboratory technicians were
specially trained for this purpose and the relevant techniques transferred. This field
laboratory is also continuously supporting routine diagnosis at the War Memorial
Hospital.
Molecular typing methods and phylogenetic analysis
Different methods may be appropriate for investigating short-term (local) and
long-term (global) epidemiology (Spratt & Maiden 1999) (see p. 15 of Introduction).
In both cases they should have an adequate level of discrimination such that isolates
assigned to the same molecular type are likely to be descended from a recent common
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ancestor, and isolates that share a more distant common ancestor are not assigned to
the same type (Maiden et al. 1998).
Suitable levels of discrimination can be achieved in two quite different
approaches. In one of them, regions of the genome that are highly variable within the
bacterial population are identified and analyzed. For bacterial pathogens, several
methods based on this approach are commonly used, e.g. pulsed-field gel
electrophoresis (PFGE), and PCR with repetitive element primers, or arbitrary primers
(Achtman 1998). In these methods, restriction enzymes (or PCR primers) are chosen
that give maximal variation within the population. Consequently, the variation that is
indexed is evolving very rapidly, usually for unknown reasons (Maiden et al.1998).
The second approach is to use variation that is likely to be selectively neutral
and accumulating very slowly in the population. Although only a limited number of
alleles can usually be identified within the population by using this type of variation,
high levels of discrimination are achieved by analyzing several loci (Maidenet al.
1998). Such techniques include multilocus enzyme electrophoresis (MLEE) which is
based on the different electrophoretic mobilities of isoenzymes (Wang et al. 1992),
and multilocus sequence typing (MLST) which relies on the sequencing of gene
fragments of a number of housekeeping genes (see below) (Maiden et al. 1998).
Methods that index rapidly evolving variation are useful for short-term
epidemiology but may be misleading for global epidemiology. Several studies have
shown that techniques such as PFGE resolve isolates that are indistinguishable by
MLEE. For example, MLEE studies of populations of Salm nella enterica have
shown that disease isolates of serovar Typhi belong to one of two closely related
electrophoretic types (ETs) (Selander et al. 1990). In contrast, isolates of erovar
Typhi are relatively diverse according to PFGE (Navarro et al. 1996). PFGE is
therefore useful for studying individual outbreaks of typhoid fever because, unlike
MLEE, it identifies the microvariation that is needed to distinguish between strains
circulating within a geographic area. However, this technique is too discriminatory for
long-term epidemiology because it does not indicate that isolates that cause typhoid
fever are members of a single globally distributed clonal lineage of S. enterica
(Maiden et al. 1998).
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MLEE has been the most widely used molecular typing technique for long-term
epidemiology in recent years. This approach has helped to identify lineages that have
an increased propensity to cause disease (Caugant t al. 1987), and contributed to the
understanding of the global epidemiology and population structure of infectious
agents. For many pathogens, MLEE has identified clusters of closely related strains
(clones or clonal complexes) that are particularly liable to cause disease (Achtman
1998, Selander et al. 1987). A major problem with MLEE, however, is that the results
obtained in different laboratories are difficult to compare (Maiden et al. 1998). This
led to the recent development of the MLST, a new molecular typing technique with
considerable advantages over MLEE ( aiden et al. 1998) (see below).
Principles of multilocus sequence typing
Multilocus sequence typing (MLST) (Maiden et al. 1998) is an extension of
MLEE in which the alleles at each house-keeping locus are assigned directly by
nucleotide sequencing (Figure 8.1). Internal ~450 bp fragments of house-keeping
genes are used since such fragments can be accurately sequences on each strand with
a single pair of primers and, in most species, will provide sufficient variation to
recognize many alleles within the population (Spratt 1999). For each gene fragment,
every unique sequence is assigned as a different allele.
Because recombinational exchanges are frequent in many bacterial species, it
cannot be assumed that alleles that differ at many nucleotide positions are any more
distantly related than those that differ at a single position and, thus, no weighting to
reflect the number of nucleotide differences between alleles is permitted. Bacterial
strains are, therefore, defined unambiguously by a string of integers (the allelic
profile, or sequence type) corresponding to the alleles at each of the house-keeping
loci. The relationships between isolates are displayed as a dendogram constructed
from the matrix of pairwise differences between the allelic profiles (Maiden et al.
1998).
The use of nucleotide sequencing to assign alleles at house-keeping loci has a
number of advantages. Firstly, sequencing uncovers all variation at a locus, resulting
in many more alleles per locus than revealed by MLEE. MLST therefore achieves
very high levels of discrimination using as few as seven loci (Spratt 1999). Secondly,
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identity of alleles is unambiguous using sequence data, in contrast to MLEE where the
same lectrophoretic mobility may reflect identical or similar nucleotide sequences or,
in some cases, completely different sequences that, by chance, encode enzymes that
migrate at the same rate on a starch gel.
Figure 8.1. Multilocus sequence typing (MLST). The method for the allocation of the
allelic profile, or sequence type, of a bacterial isolate is shown. The clustering of
related isolates can be visualized as a dendogramm, constructed from the matrix of
pairwise differences between the allelic profiles of the isolates (Source: Spratt 1999).
Thirdly, the electronic portability of DNA sequences allows any laboratory to
characterize isolates of bacterial pathogens by submitting the sequences of the gene
fragments via the Internet to a central MLST Web site (http://www.mlst.net), which
holds the continually expanding database of the allelic profiles of isolates of the
species. Finally, the sequences of seven loci from thousands of isolates of each
species can be used to address aspects of their population and evolutionary biology.
MLST was initially established for Neisseria meninigitidis n 1998 (Maiden et
al. 1998). The technique was then extended to Str pt coccus pneumoniae (Enright &
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Spratt 1998), and by now, MLST typing schemes have been developed and databases
created for a number of other bacterial species (htt ://www.mlst.net).
The levels of discrimination using MLST are very high provided there is
sufficient diversity within the population to identify many alleles at each locus. As
alleles only have to differ at a single nucleotide site, this criterion will usually be met.
There are, however, a few highly uniform bacterial species where a sufficiently
discriminatory MLST scheme could not be developed (e.g. Mycobacterium
tuberculosis where house-keeping genes from different isolates are almost always
identical in sequence (Sr evatsan et al. 1997), and probably Neisseria gonorrhoeae,
which also has a low level of sequence variation within house-keeping genes
(Vázquez et al. 1993)).
Genetic population structure and molecular epidemiology of N. meningitidis
The overall genetic population structure of N. m ningitidis has been referred to
as weakly clonal, since it comprises panmictic, epidemic-clonal and clonal elements
(Spratt & Maiden 1999). In the case of a weakly clonal pathogen like N. meningitidis,
the fact that a localized outbreak is caused by a single strain can be established using a
sufficiently discriminatory method like PFGE, since the common ancestor of the
isolates occurred so recently that there has been insufficient time for variation to
accumulate in such an extent, that different strains belonging to the same lineage
would not be recognized. During our investigation of an outbreak of serogroup X
meningococci the different PFGE could clearly be assigned to specific clusters
(Chapter 5), although we observed a considerable amount of variation generated over
a short time period.
However, it becomes more difficult to show whether an outbreak strain belongs
to one of the previously described clones associated with disease by comparing it to
reference isolates from other countries, as substantial diversification of these clones
will have occurred since the outbreak strain and the other members of the clone had a
common ancestor (Spratt & Maiden 1999). Techniques that index selectively neutral
variation and include many loci (e.g. MLST) are ideal for recognizing close
phylogenetic relationship of these clones since r combinational exchanges that alter
the alleles at one or two of the loci do not prevent their recognition as members of the
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clone using clustering techniques (Maiden et al. 1998)). We studied the population
structure of serogroup X meningococci by comparing strains isolated in different parts
of the world, and identified two clonal groupings based on this technique (Chapter 6).
However, the relationships between the deeper branches of a phylogenetic tree will be
unreliable, since the descendants of an ancestral bacterium will relatively rapidly (on
an evolutionary scale) accumulate at least one nucleotide difference in each of the
seven loci, such that many of the isolates within the population will differ at all or
most loci (Spratt 1999).
In the work presented here, the main approach included a combination of
PFGE and MLST analyses. Most isolates recovered from patients or assymptomatic
carriers were first analyzed by PFGE since this technique is considerably faster and
cheaper than MLST. We used PFGE to analyze outbreaks of serogroup A and
serogroup X meningococci in the Kassena-Nankana district (Chapters 3 and 5), to
compare the outbreak strains to isolates recovered from healthy carriers in the district
(Chapter 5 and Appendix 1), and to define two finer groups or genocloudswithin one
of two serogroup X clonal groupings identified in combination with the MLST
analysis (Chapter 6; see below). MLST analysis was restricted to selected isolates
representative of the potential clon l groupings identified during the PFGE analysis
(Chapters 3, 4 and 6). Both PFGE and MLST were used to confirm the common
identity of non-groupable (NG) isolates and corresponding serogroupable strains
(Chapter 7), and to compare serogroup W135 strains isolated in different African
countries (Appendix 2).
‘Mid-term’ epidemiology and RFLP typing of ser group A meningococci
Based on MLEE and MLST analysis, serogroup A meningococci can be further
divided into nine clonal groupings or subgroups (Wang et al. 1992). The genetic
population structure of these bacteria is more clonal than that of other meningococci
(Bart et al. 2001), and some of these subgroups have been causing pandemics of
epidemic disease during the last decades (Achtman 1995b, Morelli et al. 1997).
In order to elucidate the micro-evolutionary changes during the epidemic spread
of these bacteria, an approach using restriction fragment length polymorphism (RFLP)
typing of a number of p lymorphic genes encoding outer membrane and secreted
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proteins has been applied (Morelli et al. 1997). It is assumed that these genes are
under immune-selection and, therefore, may evolve at a higher rate than house-
keeping genes (Linz et al. 2000). This RFLP analysis revealed that, within the
subgroup III meningococci, so-called ‘pre-Mecca’ bacteria can be differentiated from
‘post-Mecca’ organisms (Morelli et al. 1997). We used a similar approach to confirm
that the serogroup A subgroup III meningococci isolated during the outbreak in the
Kassena-Nankana district belonged to the same pandemic wave caused by the post-
Mecca bacteria (Chapter 3).
This approach was subsequently extended and used for the analysis of a large
collection of subgroup III meningococci (Chapter 4). In addition to the genes encoding
outer membrane and secreted proteins, one house-k eping gene and one insertion
sequence were included in the RFLP analysis, covering a total of 6 polymorphic loci.
RFLP analysis of these 6 loci allowed the differentiation of 9 finer groups within
subgroup III meningococci, and led to the development of the genocloud concept
(Chapter 4).
Serological classification systems
Traditionally, meningococci have been classified according to several
serological schemes. Serogrouping is based on structural differences in the capsular
polysaccharides and is performed with polyclonal antisera (Achtman 1995b, Poolman
et al. 1995). Horizontal genetic exchange can lead to acquisition of genes encoding
foreign capsular polysaccharides (Swartley et al. 1997, Vogel t al. 2000). Although
we identified strains which had switched off their capsular expression (Chapter 7), we
did not observe any case of capsule-exchange during our study. Meningococci express
five different classes (designated 1 to 5 based on differences in molecular weight) of
so-called major outer membrane proteins (OMP) (Poolman et al. 1995). Class 1
(PorA) and class 2 and 3 proteins (PorB) are porins. They form the basis for ser type
(class 2 and 3) and serosubtype (class 1) which are determined using murine
monoclonal ntybodies (Wang et al. 1992). Although these serological classification
methods are relevant for accurate immunization programs (serogrouping) and for the
development of protein-based vaccines (serotyping/subtyping), they are generally
unsuitable for epidemiology because they are based on variable phenotypes which are
not necessarily related to genetic descent (Achtman 1998). In some cases, certain
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serological variants are characteristic of individual clonal groupings determined by
genetic methods (Achtman 1995b). For example, subgroup III meningococci have
usually the A:4,21:P1.9,20 phenotype (Chapter 3 & 4)(Wang et al. 1992). During our
analysis of serogroup X meningococci, we identified two clonal groupings. Members
of the first one were all X:21:P1.16 and bacteria belonging to the second X:NT:P1.5
(Chapter 6).
8.2 Implications of the main findings and suggestions for future research
Many epidemiological characteristics of meningococcal disease in Africa were
recognized shortly after the first epidemics were observed on the continent
(Greenwood 1999). The limited area of occurrence of these epidemics was described
in detail 40 years ago (Lapeyssonnie 1963), and substantial new epidemiological
insight has been gained since then (Gre wood 1999, Moore 1992). However, major
epidemics continue to occur in the African meningitis belt and they are still as
unpredictable as they always have been (Tikhomirov et al. 1997).
The characteristic epidemiology of meningococcal disease in Africa
One of the major additions of the work presented in this thesis is the contribution
to the insight in the epidemiology of meningococcal disease in the African meningitis
belt, which differs substantially from that in Europe and North America. Large
serogroup A epidemics used to occur regularly on the later continents until World War
II and have become very rare since then; a phenomenon that cannot be explained
satisfactorily (Cartwright 1995a). In contrast, such epidemics have been reoccurring
every 8 – 12 years in the countries of the African meningitis belt since the beginning
of the century (Greenwood 1999) (Chapter 3 and 4). Also in 2001, several countries of
the African meningitis belt were hit by severe epidemics (WHO 2001b). Serogroup B
meningococci are the major cause of m ningococcal disease in industrialized
countries, but they are only very rarely isolated in countries of the African meningitis
belt (Chapter 5). Meningococcal carriage is around 10% in the general population of
Europe and the USA (Cartwright 1995b), ut seems to be lower during interepidemic
periods in Africa (Chapter 5). Furthermore, carriage of non-serogroupable strains,
making up to 50% of the meningococci carried in Europe and the USA is especially
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low in Africa (Chapter 7). In the African meningitis belt, meningococcal colonization
appears to occur in waves and is not influenced by carriage of Neisserialactamica
(Chapter 5). It has been suggested that the later might protect against meningococcal
colonization and disease based on studies conducted in Europe and the USA (Gold et
al. 1978b, Olsen et al. 1991). The genetic diversity of meningococci carried by the
general population seems also lower in Africa than in Europe and the USA (Chapter 6
and 7) (see below).
There are many factors that could be relevant for the enhanced susceptibility for
epidemic meningococcal disease in the African meningitis belt. Populations in this
area live often under poor social-economic conditions and under low standards of
hygiene and nutrition. They are constantly confronted with many other infectious
diseases. Furthermore, the climatic conditions are severe during the Sahelian dry
seasons, a factor contributing to the deterioration of the mucosal d fenses. However, it
is much harder to explain why, except during epidemic periods, mening coccal
carriage in general, and especially carriage of meningococci which are non-
serogroupable and unrelated to the epidemic strains, is less frequent in Africa than in
Europe and the USA.
The following is a speculative attempt to explain the differing epi emiology of
meningococcal disease in Africa and in the industrialized countries. Until World War
II, serogroup A was the main cause of m ningococcal disease and caused large
epidemics in Europe and the USA, similar to the current situation in the African
meningitis belt (Cartwright 1995a). Since then, serogroup A has become very rare in
the developed world and country epidemics with high attack rates have mainly given
way to hyper-endemic waves and focal outbreaks. What caused the epidemiology of
meningococcal to change so dramatically in Europe and the USA? One possible
explanation is that through improved general sanitation, organisms competing with
the meningococci on the nasopharyngeal surface were removed, leaving an open
niche for a wider spectrum of meningococci to establish themselves. We found many
more commensal organisms in Ne sseria selective agar plates inoculated with throat
swabs from the Kassena-Nankana district than are generally found with European
specimens.  In contrast to the African meningitis belt, meningococcal carriage in
Europe and the USA is high and endemic, and it seems that a persisting flora of very
heterogeneous meningococci has established itself, many of which are non-capsulated
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and thus probably better adapted to prolonged carriage. The carriage of such a
resident flora of non- or less pathogenic meni gococci could, through immunological
and ecological effects, contribute to a reduced susceptibility to disease, and hinder the
epidemic spread of serogroup A bacteria in Europe and the USA. Some evidence
supports this hypothesis. After the 1987 s rogroup A subgroup III epidemic in Mecca,
many pilgrims of industrialized countries brought the epidemic strain back home.
However, this strain could not establish itself in these countries and caused only very
few cases of disease outside the African meningitis belt, where, during the following
years, large epidemics of disease occurred in many countries.
In the African meningitis belt, the limited pool of meningococcal types
includes strains of high virulence able to cause epidemics of disease (i.e. serogroup A
bacteria). Furthermore, the low humidity prevailing during the Sahelian dry seasons
favors disease, although it has no effect on carriage and is therefore not important for
transmission (Greenwood et al. 1984) (Chapter 5). Other strains with increased
transmissibility but low virulence may occasionally break through and cause an
epidemic of carriage without much disease, similarly to what we observed in the case
of a specific clonal grouping of serogroup X bacteria (Chapter 5).
Additional insight would be gained by conducting carriage surveys during
large epidemics in the African meningitis belt in neighboring regions, which lay
further to the south and outside the meningitis belt. Such studies would show whether
carriage of the epidemic strains is restricted to the population of the area affected by
the disease epidemics or, alternatively, whether epidemic zones share patterns of both
the epidemic and other strains with the neighboring (more humid) areas outside the
meningitis belt.
More insight into the immune processes related to colonization and disease is
needed in order to be able to test such hypotheses. One suggestion for future research
would be to attach an immunological component to the ongoing carriage surveys.
Longitudinal sero-epidemiological surveys could be performed with the aim i) o
follow the changes in herd immunity to specific capsular and outer membrane protein
antigens, ii) to try to determine the relative contribution of these different immune
responses to the overall protective immunity, iii) to establish the role of mucosal
immunity, and iv) to relate the immune response to the type of meningococci arried.
Furthermore, the m ningococci specific immune status of populations of the African
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meningitis belt could be compared to that of populations in Europe or the USA in
order to find differences that could contribute to the understanding of the strikingly
different epidemiologies in the two regions. However, such longitudinal sero-
epidemiological studies would require repeated blood drawings which are associated
with substantial ethical, social-cultural and logistical difficulties.
Pathogenic potential of serogroup X meningococci
Another main finding is the documentation of a serogroup X meningitis outbreak
in Ghana (Chapter 5). This observation has two important implications. The first one
concerns the genetic population structure of serogroup X bacteria in Africa and the
other the potential impact of vaccination programs on the general population structure
and serogroup distribution of meningococci in Africa (see below).
Two outbreaks of serogroup X meningitis have been reported in Niger
previously (Campagne et al. 1999, Etienne et al. 1990), and our results show that the
most recent of these two outbreaks and the KND serogroup X outbreak were caused
by meningococci belonging to the same clonal grouping (Chapter 6). Furthermore,
bacteria belonging to this clonal grouping include the vast majority of serogroup X
meningococci isolated in Africa, including strains isolated in the 1970s in Mali
(Chapter 6). Recent results, based on an extensive phylogenetic analysis including all
meningococcal MLST sequence types present in the MLST database
(http://www.mlst.net), suggest that serogroup X bacteria from Africa are clonal,
similar to the subgroups of erogroup A meningococci (Thierry Wirth, personal
communication) (Bart et al. 2001). Although, we identified another clonal grouping
within serogroup X bacteria from Europe and the USA, a large proportion of the
European and American isolates were very diverse (Chapter 6).
What could explain the apparent lack of heterogeneity within the African
serogroup X meningococcal strains? Meningococci are naturally transformable and a
high rate of recombination has been observed in these bacteria (Feil et al. 1999, Jolley
et al. 2000), especially through horizontal genetic transfer from other meningococci or
even other Neisserial species (Linz et al. 2000). A possible explanation is that in the
African meningitis belt, the relative low levels of carriage of meningococci unrelated
to the epidemic strain (Chapter 5 and 7) could limit the opportunities for horizontal
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genetic transfer. However, we found that the epidemiology of carriage of Neisseria
lactamica in Ghana did not differ significantly from that in Europe or the USA
(Chapter 5) (Cartwright 1995b). On the other hand, DNA transfer and/or integration
between N. meningitidis and N. lactamica might be less frequent since the sequence
diversity between the two species is larger.
The characterization of the isolates collected during the ongoing carriage
surveys will provide additional insight in the genetic population structure of
meningococci in Ghana. However, similar studies carried out in other parts of Africa
are required to elucidate the overall population structure of meningoc cci resident in
the African meningitis belt.
Vaccine impact
The introduction of any vaccine that targets only a fraction of the population of a
bacterial pathogen has been referred to as a large-scale experiment in bacterial
population biology, the outcome of which cannot be fully predicted (Maid n & Spratt
1999).   In fact, a change in serotype distribution has been observed in the carriage of
Streptococcus pneumoniae after the introduction of a polyvalent capsular
polysaccharide conjugate vaccine (Mbelle et al. 1999, Obaro et al. 1996). For over a
decade, serogroup A + C polysaccharide meningococcal vaccines have been
extensively used to combat epidemics in many countries (Tikhomirov et al. 1997).
These vaccines do not seem to affect carriage (Bl kebrough et al. 1983, Hassan-King
et al. 1988). However, the recent outbreaks of serogroup X in Niger and Ghana, and of
serogroup W135 in Mecca (Taha et al. 2000, WHO 2001a) may reflect a selection of
former rare s rogroups that are not included in the vaccine.
The implementation of immunization programs in the African meningitis belt
with future serogroup A + C polysaccharide protein conjugate vaccines, which are
very likely to affect carriage, will probably create a strong selection pressure against
serogroup A and serogroup C meningococci. After the introduction of such vaccine
programs, an effective surveillance should therefore be established, in order to capture
a potential increase in disease incidence due to serogroups not included in the vaccine.
In terms of future research, efforts should be directed towards the development
of a polysaccharide protein conjugate vaccine that would also include rare capsular
polysaccharide variants (i.e. serogroup W135 and X), or a broadly reactive and
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potentially less expensive protein-based vaccine. Immunization programs with such
vaccines might have less undesirable long-term side effects.
8.3 Conclusions
The epidemiology of meningococal meningitis was investigated in the
Kassena-Nankana district (KND) in Northern Ghana. Conventional epidemiological
tools were used to determine patients and carrier characteristics. Several molecular
typing and phylogenetic analysis techniques were applied to characterize the bacterial
isolates, and to compare them to other meningococcal strains isolated in different
regions of the world. Based on the findings generated during these studies, the
following conclusions could be drawn.
1. The meningitis outbreak that occurred in the KND in 1998 was caused by
serogroup A subgroup III post-Mecca meningococci. Thus, this outbreak was part
of the second pandemic wave caused by serogroup A subgroup III bacteria (see
below). The rather high case-fatality ratio observed during this outbreak can be
most likely attributed to late-arrival at the health facilities. Serogroup A subgroup
III meningococci can be further divided into nine genoclouds. These genoclouds
consist of fit genotypes that were isolated repeatedly and of closely related escape
variants which are mostly less fit than their parents. These escape variants are
subsequently lost because of competition and bottlenecks during spread from
country to country. These nine genoclouds have caused three pandemic waves of
disease since the mid-1960s, the most recent of which was imported from East
Asia to Europe and Africa in the mid-1990s. These observations raise the
possibility of renewed epidemic s rogroup A disease in Europe and the Americas.
2. Two years following the serogroup A meningococcal disease epidemic that
occurred in the KND in 1997/98, a carriage epidemic of s rogroup X
meningococci with a number of associated serogroup X meningitis cases was
observed. This illustrates the pathogenic and even epidemic potential of serogroup
X bacteria. These rogroup X bacteria were very likely to have been newly
introduced into the district, since no such strains had been isolated during two
preceding surveys. While carriage of serogroup A was decreasing between 1998
and 2000, carriage of serogroup X increased very strongly. Only a few other
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meningococcal isolates, unrelated to the dominant serogroup A and X strains,
were recovered during the carriage surveys. These findings support the hypothesis
that, in the African meningitis belt, meningococcal colonization occurs in wave,
and that depending on the virulence of the strain involved in the process,
epidemics of disease occur. Carriage of Neisseria lactamica had no effect on the
dynamics of meningococcal carriage, and therefor does not seem to protect against
colonization of the nasopharynx by meningococcal strains.
3. Although most of the serogroup X meningococci recovered in different countries
of Africa, Europe and North America were diverse, two clonal groupings were
identified. One clonal grouping included strains isolated from patients and healthy
carriers in several countries of Europe and the USA over the last two decades. The
second clonal grouping comprised the large majority of se ogr up X bacteria
isolated from countries of the African meningitis belt since the early 1970s. Based
on the PFGE results, two genoclouds were identified within the second clonal
grouping. Bacteria belonging to the first genocloud caused an outbreak in Niger in
1997 and bacteria belonging to the second caused the outbreak in KND in 2000.
These observations support the concerns raised about the potential vaccine-
induced selection of serogroups not included in the polysaccharide vaccines,
which have extensively been used in the African meningitis belt for more than a
decade.
4. In contrast to Europe and the USA, carriage of non-s r gr upable meningococci
is infrequent in the African meningitis belt. This finding supports the hypothesis
that a lack of protective cross-reactive immunity against pathogenic strains might
be caused by such an infrequent carriage of non-ser groupable meningcocci. This
could increase the susceptibility to epidemic disease in the populations of the
African meningitis belt.
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APPENDIX 1
Long-term carriage of a serogroup A (subgroup III) epidemic
Neisseria meningitidis strain in Northern Ghana
During a longitudinal carriage study carried out in the Kassena-Nankana district
of Northern Ghana, the five 6-monthly surveys of 300 randomly selected individuals
revealed a gradual decrease in carriage of serogr up A subgroup III meningococci
(Chapter 5). Analysis by pulsed-filed gel electrophoresis (PFGE) (Morelli et al. 1997)
showed that all carriage isolates were very similar to disease isolates recovered from
meningitis patients during the 1998 outbreak in the same district (Chapter 3; Figure
9.1). Multi locus sequence typing of selected isolates revealed ST5 which is typical for
subgroup III bacteria (Chapter 4). One person was found to be carrying these bacteria
at four consecutive surveys (Figure 1; number 1: tracks 4-7). However, after digestion
of chromosomal DNA with NheI and SpeI, three different combined PFGE patterns
were observed. Since this individual was carrying the same PFGE variant in the first
and the 4th survey (Figure 9.1; tracks 4 and 7), it is not clear whether this person had a
mixed colonization with closely related bacteria belonging to the same genocloud or
experienced re-colonization (his wife was carrying the variant found in the 1st and 4th
survey during the second survey; track 8).
A second individual was carrying two different PFGE variants at two
consecutive surveys (Figure 1; tracks 9 and 10). Since up to 10 colonies have been
picked and stored from each individual at each survey, PFGE analysis of all these
isolates may help to determine whether these two individuals were carrying a mixed
population or were re-colonized.
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Figure 1. PFGE patterns of NheI and SpeI digested chromosomal DNA of ser group
A subgroup III meningococci from Northern Ghana. Strains were loaded in tracks 1-
19 in the following order (track: strain): 1:Z7057; 2: Z7060; 3: Z7067; 4: Z8318; 5:
Z8324; 6: Z8326; 7: Z9567; 8: Z8349; 9: Z8314; 10: Z8323; 11: Z8315; 12: Z8316;
13: Z8322; 14: Z8325; 15: Z8318; 16: Z8320; 17: Z8321; 18: Z8342; 19: Z8317.
Molecular weight markers were loaded in the flanking tracks as indicated (LM: low
range marker; MM: midrange marker); thei  molecular weights are indicated at the
left. CSF indicate isolates recovered from meningitis patients during the 1998 outbreak
in the Kassena-Nankana district of Northern Ghana (Chapter 3). All other strains were
isolated from healthy carriers (Chapter 5). Number 1 and 2 indicate sequential isolates
from the same persons.
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APPENDIX 2
Carriage of serogroup W135 (ET-37 complex) strains in Northern
Ghana
We conducted a three-year longitudinal carriage study in the Kassena-Nankana
district of Northern Ghana, during which two serogr up W135 isolates were recovered
in 1998 (Chapter 5). We compared these strains by pulsed-field electrophoresis
(PFGE) (Morelli et al. 1997) to other serogroup W135 strains isolated in 1993 and
1995 in The Gambia and Mali (Kwara et al. 1998). All these isolates had very similar
SpeI and NheI fingerprints (Figure 9.2). Multi locus sequence typing revealed
sequence type (ST) 11 which is typical of ET-37 complex strains (Maiden et al. 1998).
Isolates of ST11 have typically been serogroup C, but occasional serogroup B, W135,
and non-groupable strains with this ST have been observed (Wang et al. 1993). In
2000, W135, ST11 bacteria caused a disease outbreak with more than 200 cases
during the annual H jj pilgrimage in Mecca (WHO 2000b). Subsequently, meningitis
cases were observed among pilgrims returning to France, the UK, the Netherlands,
Oman, Kuwait, Singapore, Indonesia, and the USA, as well as among their close
contacts (Popovic et al. 2000, Taha et al. 2000). Analysis by PFGE revealed that this
outbreak was clonal and that the outbreak strains were closely related to the serogroup
W135 meningococci isolated several years earlier in The Gambia, Mali and Ghana
(Taha et al. 2000).
Figure 9.2. PFGE patterns of SpeI and NheI digested chromosomal DNA of ser group
W-135 meningococci from The Gambia, Ghana and Mali. Strains were loaded in
tracks 1-9 and 10-18 in the following order (track: strain): 1/10:Z6196; 2/11: Z6206;
3/12: Z6209; 4/13: Z6212; 5/14: Z6216; 6/15: Z6218; 7/16: Z8343; 8/17: Z8344; 9/18:
Z6351. Molecular weight markers were loaded in the flanking tracks as indicated (LM:
low range marker; MM: midrange marker); their molecular weights are indicated at
the left. SpeI : track 1-9; NheI: tracks 10-18.
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